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Abstract 
 
Background: Research has shown that the emotional impact of cancer can be more 
difficult to cope with than practical or physical demands and a diagnosis can have 
significant short- and long-term psychological sequalae including depression, anxiety, 
difficulties in adjustment and coping and associated poor quality of life (Vachon, 2006). 
The common-sense model of illness representations has been widely cited as a useful 
theoretical framework to explain how individuals with chronic illnesses such as cancer 
think about and respond to their condition (Leventhal & Nerenz, 1985). Aims: Two 
systematic reviews were conducted to identify studies that had measured the prospective 
relationship between illness representations and the psychological health of cancer 
patients (Review 1) and to identify studies that had developed interventions to modify the 
illness perceptions of cancer patients to improve their psychological health (Review 2). 
Methods: Using best practice guidelines for systematic reviews (Centre for Reviews and 
Dissemination, 2009) two independent systematic reviews were conducted. Results: 
Review 1 identified seven studies that had measured the prospective relationship between 
illness perceptions and psychological health outcomes in cancer patients. The majority of 
these studies found that patients with the most negative illness perceptions had the 
poorest psychological health in the future. Review 2 identified thirteen studies that had 
developed interventions to either directly target illness perceptions or had hypothesised 
that other types of intervention would indirectly change patient’s cancer related illness 
perceptions. Findings revealed some interventions were more effective than others in 
improving the psychological health of cancer patients, largely depending on their design 
and content. Discussion: Illness perceptions were overall predictive of several 
psychological health outcomes in cancer patients although there was a lack of 
methodological consistency in the measurement of illness perceptions making synthesis 
challenging.  Interventions were more likely to be effective if they did not specifically 
target illness perceptions and if they were comprised multiple ‘active’ components 
including increased access to social support, homework based activity, group discussion, 
skills based training and improving the expression of emotions. Relaxation training 
appeared to be a significant component useful in facilitating psychological improvements 
in this patient group. Conclusions: Future research would benefit from further 
exploration of the process of change in such complex interventions in order determine 
which ingredients or indeed combination of ingredients are necessary for interventions to 
be effective in improving psychological health.  
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1 
INTRODUCTION 
 
 
1.1. Overview 
1.1.1. Chapter structure 
This chapter will first present the broad aims and rationale of the thesis. Background 
evidence highlighting the psychological impact of cancer and the need for psychological 
support will then be discussed. The common-sense model - a theoretical model of 
understanding the ways individuals with a chronic condition may think about and 
respond to their illness (Leventhal, Meyer, & Nerenz, 1980) will be described alongside 
research highlighting the potential impact of these beliefs on psychological health. A 
broad description of the literature base to be reviewed will be outlined along with the 
potential benefits of this review and specific research questions to be addressed. 
 
 
1.1.2. Rationale, aims & methods 
There are many well cited psychological sequalae associated with receiving and coping 
with a cancer diagnosis (see 1.2.1.). This thesis has two broad aims and will address 
these aims using systematic review methodology to contextualise the current research. 
The first aim (addressed in Review 1) is to explore research that has used illness 
representational theory (Leventhal & Diefenbach, 1992) to better understand the 
prospective relationship between the ways in which adults with a cancer diagnosis think 
about their illness and the impact this may have upon their future psychological health. 
A second aim (addressed in Review 2) is to examine whether interventions to modify 
‘negative/maladaptive’ illness perceptions have been useful in improving the 
psychological health of such patients.  
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1.2. Background 
1.2.1. The psychological impact of cancer 
In 2013 more than 352,500 people were diagnosed with cancer in the UK and there 
were more than 163,000 deaths from cancer the following year 
(http://www.cancerresearchuk.org/cancer-info/cancerstats). Undoubtedly, receiving a 
cancer diagnosis causes significant distress to patients and their families and empirical 
evidence exploring both short- and long-term psychological sequalae of receiving a 
diagnosis and undergoing treatment has found high levels of depression, anxiety, 
difficulties in adjustment and coping and associated poor quality of life to be common 
within this patient population (Vachon, 2006; Zabora, BrintzenhofeSzoc, Curbow, 
Hooker, & Piantadosi, 2001). Evidence has also shown that the psychological 
consequences of cancer can endure beyond diagnosis and treatment into long term 
survivorship for a significant proportion of patients, impeding efforts to ‘return to 
normal’ (Arndt, Merx, Stegmaier, Ziegler, & Brenner, 2005; Hoffman, McCarthy, 
Recklitis, & Ng, 2009; Macmillan Cancer Support, 2013).  
 
1.2.2. The need for psychological support 
The UK government has recognized the psychosocial impact of cancer and highlighted 
the importance of providing psychological support to patients and their families, 
particularly in cases of anxiety and depression (Department of Health, 2015).  A survey 
of 1,751 people affected by cancer to assess the emotional impact of the disease 
(Macmillan Cancer Support, 2006) found that 45% of people with cancer found the 
emotional aspects of cancer care more difficult to cope with than practical or physical 
demands. However, while 75% of people with cancer said they had experienced anxiety 
and 49% had experienced depression after their diagnosis, only half of these individuals 
said they had received information, advice, support or treatment from clinicians to deal 
with this. Lack of psychological support has been shown to lead to poorer quality of 
life, exacerbation of physical health symptoms and subsequent increases in health care 
costs (Carlson & Bultz, 2004). Nearly two thirds of people affected by cancer said the 
emotional effects of having a cancer diagnosis should be the top priority in cancer 
support, ahead of medical management and practical aspects (Macmillan Cancer 
Support, 2006). Clearly there is a need to understand the way individuals think about 
living with and beyond cancer diagnosis and treatment in terms of the likely negative 
impact on their psychological health. The following subsection will outline one model 
which has been shown to be useful in increasing this understanding.  
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1.3. Understanding and coping with illness 
1.3.1. Common sense model of illness representations 
Many theoretical models have been proposed to explain the ways individuals perceive 
and respond to illness (Connor & Norman, 1995). A widely cited model within the 
chronic illness literature is the common-sense model (CSM) of illness representation 
(Leventhal, Nerenz, & Steele, 1984; Leventhal & Diefenbach, 1991). The CSM 
provides a framework for understanding how the perceptions individuals hold about 
their illness can affect their adjustment to having the condition.  
 
The model proposes that when individuals are diagnosed with an illness they develop a 
cognitive and emotional ‘representation’ to help them make sense of and cope with the 
condition. This self-regulated representation comprises several perceptions about the 
illness and will be described in more detail below. Coping is considered by the CSM to 
be a mediator of the relationship between an illness representation, and illness 
behaviours and subsequent outcomes. The model also proposes a feedback loop where 
individuals appraise the efficacy of their chosen coping strategies. This appraisal is 
thought to influence their current representation and modify future coping responses. 
The CSM was conceptualized by Leventhal et al. as a parallel processing framework 
whereby internal or external stimuli are cognitively processed across one processing 
pathway while a second parallel pathway processes emotional aspects of that stimulus 
(Figure 1).  
 
 
Figure 1: Common sense model of illness 
(Leventhal & Diefenbach, 1992) 
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The CSM conceptualises individuals as active problem solvers who can use abstract and 
concrete sources of information to process their cognitive perceptions and emotional 
reactions to a health threat to guide their coping response. The model proposes that 
individuals use lay information (already known to them from past social communication 
and cultural knowledge of the illness), external/social information (from significant 
others and/or authoritative sources) and somatic information from their current 
experience of the illness to form an illness representation and engage a coping response.  
 
After the development of the CSM, studies consistently identified four distinct 
dimensions of illness representation in a wide range of chronic health settings: 
‘identity’, ‘cause’, ‘consequences’ and ‘timeline’. Illness identity relates to an 
individual’s beliefs about the illness label (e.g. I think I have cancer) combined with 
knowledge about its symptoms (e.g. cancer will cause me lots of pain). The cause 
dimension relates to perceptions about the potential cause(s) of illness (e.g. cancer is 
caused by being unhealthy). Research has identified several factors patients might 
perceive as causing their illnesses, such as biological (e.g. genetic, immunity; Heijmans, 
1998), psychological (e.g. personality traits, overwork/stress; Moss-Morris, Weinman, 
Petrie, Horne, Cameron & Buick, 2002), emotional (e.g. depression; Moss-Morris, 
Petrie, & Weinman, 1996) and environmental (e.g. pollution; Heijmans, 1998). The 
consequences of illness are those variables believed by an individual to impact on their 
physical, social and psychological functioning (e.g. cancer will have serious health 
consequences). The timeline component refers to an individual’s beliefs about the likely 
duration of their illness and symptoms (e.g. cancer will be in my life for a long time/is 
likely to recur) and have been categorised as acute/short lasting, chronic or 
cyclical/episodic (Weinman, Petrie, Moss-Morris, & Horne, 1996). Later work extended 
the framework and added a fifth component to the model which represented beliefs 
about the ‘cure and controllability’ of the illness (e.g. cancer cannot be cured or 
controlled by treatment/me) (Lau, Bernard, & Hartman, 1989). This component reflects 
the extent to which an individual believes their illness is controllable by themselves or 
others, or can be cured (e.g. taking this medication will cure my disease/relieve my 
symptoms).  
 
As an example of how illness perceptions are generated in response to a health threat 
such as cancer, an individual who finds a lump in their breast may identify this as the 
first symptom of breast cancer (identity). They may believe they are predisposed to 
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developing breast cancer (genetic causation) and determine from personal experience 
this is likely to be a chronic condition (timeline). They may also believe that there is 
likely to be a significant impact of having cancer such as giving up work and effects on 
relationships (consequences), and that it will not be cured by anything they can do but 
may respond to cancer treatments such as surgery or chemotherapy (cure/control). Their 
coping response may be to seek medical advice.  
 
The CSM asserts that individuals will continuously appraise, evaluate and modify the 
outcome of their coping response in light of new information or an outcome which was 
not expected (Leventhal & Diefenbach, 1992).   For example, if the person described 
above then discovers the lump has disappeared the following day, their earlier illness 
identity ‘cancer’ may need to be revised and a new coping response selected.  
Unsurprisingly, the way in which an individual identifies a health threat is believed to 
have a significant impact on their emotional response. For example, a lump in the breast 
may be labelled by one individual as breast cancer but by another as a normal breast 
tissue change as a result of normal hormonal changes, depending on the information 
they have used to reach their respective illness perceptions. The resulting emotional 
representation for each of these individuals will understandably be vastly different. 
 
Diefenbach and Leventhal (1996) suggest that cognitive and emotional processing 
occurs in parallel and are idiosyncratically driven depending on an individual’s history, 
personality disposition and their interpersonal and cultural context. These parallel 
processes and continued reappraisal will shape their coping response. Experiences of 
prior illnesses can generate memories or provoke feelings of anxiety, even on a 
subconscious level, which can have an influential effect on the cognitive and emotional 
representations of future health threats and subsequent coping responses (Leventhal & 
Everhart, 1979). For example, an individual who has a family history of breast cancer 
will be understandably more fearful of this happening to them. They may be more likely 
to interpret a breast lump as cancer than someone who does not have a family history of 
cancer and will this be more anxious about finding a lump. 
 
 
1.3.2. Measuring illness perceptions 
Early data on illness perceptions was largely obtained using open-ended unstructured 
interviews or descriptions of illness episodes (Baumann, Cameron, Zimmerman, & 
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Leventhal, 1989; Dempsey & Dracup, 1995; Leventhal & Nerenz, 1985; Savage & 
Clarke, 1998). While evidence consistently supported the stability of the five 
components of illness representations -identity, cause, cure, consequence and timeline - 
across a range of chronic illnesses (Lau & Hartman, 1983; Linz, Penrod & Leventhal, 
1982), this methodology has been criticised as being limited by small sample sizes and 
having produced wide variations in the quantity and quality of responses thus 
(Weinman et al., 1996).  
 
To overcome this, researchers attempted to operationalise the five components of illness 
representations by developing quantitative questionnaires. Turk, Rudy and Salovey 
(1986) for example, developed the 45-item Implicit Models of Illness Questionnaire 
(IMIQ) to assess CSM components. Their initial study administered the measure to 
healthy college students, diabetic patients and teachers working in a diabetic setting. 
Findings from this study and others using the IMIQ or other idiosyncratic 
questionnaires within different patient populations (Schiaffino & Cea, 1995; Heijmans 
& de Ridder, 1998; Lacroix, 1991) report different structures of illness representation 
components to those originally proposed by Leventhal. The questionnaire development 
of such studies has come under scrutiny and have been criticised as being 
unrepresentative of the CSM and the original work by Leventhal et al. explaining why 
findings have not been comparable. Inconsistent findings have been described as 
‘design and analysis artefact’ rather than contradictory evidence for the five components 
of the CSM (Weinman et al., 1996).  
 
As a means of more accurately representing and quantifying illness perceptions across a 
range of illnesses, Weinman et al. (1996) developed the Illness Perception 
Questionnaire (IPQ). It was anticipated this self-report measure would, unlike previous 
measures, be theoretically based and could be psychometrically tested for validity and 
reliability. The IPQ was developed to be generalizable across multiple patient 
populations and flexible, so that items relevant to specific illnesses or health contexts 
could be added or modified where necessary without compromising psychometric 
stability. The measure comprised items representing five illness perception components; 
identity, timeline, consequences, cure/control and cause. The identity subscale 
comprises 12 ‘core’ symptoms (based on the 12 most common generic symptoms from 
other symptom checklists; Bowling, 1991) that could be added to in order to tailor the 
subscale depending on the specific illness being measured. A further 26 items to 
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represent the other four illness perception subscales were generated, partly by the 
researchers based on their knowledge of the CSM, and during interviews with patients 
with a range of illnesses (including diabetes, asthma, myocardial infarction and 
rheumatoid arthritis) (Weinman et al., 1996).  
 
Psychometric evaluation of the IPQ and subscales revealed good internal reliability 
(Weinman et al., 1996).  Within this study, Weinman et al. also compared the amount 
of information disclosed by patients during both qualitative interviews and on the IPQ. 
Findings revealed that the IPQ had good concurrent validity with patient’s responses 
during structured interviews but that significantly more information about illness 
perceptions was obtained from the IPQ than in interviews. The IPQ was also shown to 
have good predictive validity: patient’s IPQ scores were predictive of several self-
reported health outcomes such as the number of doctor visits, perceived control over 
problems and likelihood of future health problems. This validity was maintained 3 
months later (Weinman et al., 1996).  
 
To strengthen the psychometric properties of the IPQ, extend its generalizability further, 
and better represent the CSM, the IPQ was revised in 2002 (IPQ-R; Moss-Morris, et al., 
2002; Appendix I). As had been proposed earlier (Horne, 1997), this study found the 
scale measuring the component cure/control was comprised of two distinct subscales, 
‘personal control’ (beliefs about how much personal behaviour can influence the illness) 
and ‘treatment control’ (beliefs about the perceived effectiveness of treatment). The 
IPQ-R also added new items to represent cyclical timeline beliefs as well as items to 
assess patient’s emotional response to illness, not included in the original IPQ. Finally, 
the IPQ-R also added a sixth component, ‘illness coherence’, to assess the extent to 
which patients understand their illness in a coherent way. Psychometric evaluation of 
the IPQ-R revealed good validity and reliability in a large sample of patients (N=711) 
from eight illness populations (Moss-Morris, et al., 2002).  
 
Researchers have since developed the 9-item Brief Illness Perception Questionnaire (B-
IPQ: Broadbent, Petrie, Main, & Weinman, 2006) to reduce ‘respondent burden’ by 
including only single-item measures of each of the nine constructs; identity, cause, 
consequence, cure (personal/treatment), timeline (cyclical/acute), coherence and 
emotional representation. In a study involving a combined total of 663 renal, cardiac, 
asthma and diabetic outpatients, this measure was shown to have good test-retest 
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reliability, concurrent validity with relevant measures and predictive validity with 
physical and psychological functioning variables (Broadbent et al., 2006).   
 
 
1.3.3. Illness perception clusters 
Since the development of the IPQ in 1996 and the IPQ-R in 2002, research into illness 
perceptions has increased exponentially. The measures have been adapted and used 
widely to explore the illness perceptions of patients with a range of chronic physical 
illnesses including asthma (Horne & Weinman, 2002), rheumatoid arthritis (Murphy, 
Dickens, Creed, & Bernstein, 1999; Scharloo, Kaptein, & Weinman, 1999), diabetes 
(Griva, Myers, & Newman, 2000), motor neurone disease (Earl, Johnston, & Mitchell, 
1993), coronary heart disease (Petrie, Weinman, Sharpe, & Buckley, 1996), chronic 
fatigue syndrome (Heijmans, 1998; Moss-Morris et al., 1996) and cancer 
(Anagnostopoulos & Spanea, 2005; Buick & Petrie, 2002; Miller, Purushotham, 
McLatchie, George, & Murray, 2005).  
 
Leventhal et al. (1980) argued that a characteristic illness perception ‘profile’ of CSM 
components would depend upon the specific condition being experienced. It is beyond 
the scope of this chapter to present findings from each patient population. However, of 
relevance to these reviews, research has found a broad pattern of inter-correlations 
between the components. A meta-analysis of 45 empirical studies adopting the CSM to 
quantitatively measure illness perception clusters across 23 chronic conditions revealed 
several key findings (Hagger & Orbell, 2003). In support of earlier evidence (Heijmans, 
1998; Heijmans & de Ridder, 1998; Weinman et al., 1996), individuals with a strong 
illness identity (e.g. who associated their illness with having the most number of 
symptoms) were also those who had associated beliefs that their condition was less 
personally controllable, more chronic and had the most severe consequences on their 
lifestyle. Conversely, individuals who associated fewer symptoms with their illness 
were more likely to believe they had more personal control over their condition and that 
their illness was less chronic with fewer consequences.  
 
 
1.3.4. Modifying illness representations 
As Wearden and Peters (2008) point out in their discussion paper, most research has 
focused on describing cross-sectional associations between illness representations and 
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patient outcomes. However, there has been an increase in the last few years in the 
number of studies which have used the CSM as a framework for the development of 
interventions to modify illness representations and improve psychological health and/or 
other illness outcomes. This research has involved patients with a range of chronic 
conditions such as chronic heart disease and myocardial infarction (Broadbent, Ellis, 
Thomas, Gamble, & Petrie, 2009; Goulding, Furze, & Birks, 2010); asthma (Petrie, 
Perry, Broadbent, & Weinman, 2011), psoriasis (Fortune, Richards, Griffiths, & Main, 
2004) and cancer (Fischer, Wiesenhaan, Does-den Heijeer, Kleijn, & Nortier, 2013). 
These interventions include a cognitive-behavioural intervention to modify illness 
representations to improve self-regulation of blood glucose levels in patients with type 2 
diabetes (McAndrew, Musumeci-Szabo, Mora, Vileikyte, & Burns, 2008), an emotional 
regulation group intervention to promote emotional disclosure and reduce psychological 
distress in breast cancer patients (Cameron, Booth, Schlatter, Ziginskas, & Harman, 
2007) and a behavioural activation intervention combined with acceptance and 
mindfulness techniques to improve the emotional tolerance of patients with chronic 
fatigue syndrome (Deary, 2008). Additional illness representation interventions 
developed to improve the psychological health of cancer patients will not be described 
further in this chapter since they will be identified in Review 2 and described in full.  
 
Although there are comparatively fewer intervention studies overall (compared with 
cross-sectional correlational studies), the evidence within several chronic health 
domains does suggest that a range of intervention strategies to alter ‘unhelpful’ illness 
perceptions can be beneficial in improving illness related behaviours, illness outcomes 
and the psychological health of patients with a range of chronic health conditions. As 
such illness representations are an important and potentially modifiable target for both 
screening and intervention to improve the psychological health of patients with cancer. 
 
 
1.4. Illness representations and health outcomes 
In addition to the evidence for the existence of core illness representations in a range of 
clinical populations, studies have also explored the relationships between ‘maladaptive’ 
illness perceptions and a range of health outcomes such as disease state, health care use 
(Frostholm, Fink, Christensen, Toft, Oernboel & Oleson, 2005), physical activity and 
use of alcohol (Costanzo, Lutgendorf, & Roeder, 2011), coping (Heijmans & de Ridder, 
1998), physical adaptation (Heijmans, 1998), mood (Murphy et al., 1999) and treatment 
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adherence (Cooper, Lloyd, Weinman, & Jackson, 1999).  Such studies have consistently 
evidenced strong cross-sectional, longitudinal and prospective relationships between the 
illness representations and illness outcomes of individuals with a range of chronic long-
term health conditions such as osteoarthritis (Orbell, Johnston, Rowley, Espley, & 
Davey, 1998), psoriasis (Fortune, Richards, Griffiths, & Main, 2002), diabetes 
(Hampson, Glasgow, & Stryker, 2000) and asthma (Horne & Weinman, 2002).  
 
In their meta-analysis of 45 empirical studies across 23 illness conditions, Hagger and 
Orbell (2003), found that individuals with strong illness identities and perceptions of 
more severe consequences reported worse physical functioning. Furthermore, patients 
who perceived they had little personal control over their illness reported worse objective 
disease state outcomes, regardless of the actual severity of disease. These findings were 
in support of previous associations found between illness representations and physical 
recovery rates and increased future use of health care services (Heijmans & de Ridder, 
1998; Scharloo et al., 1999).  In terms of the relationship between illness perceptions 
and psychosocial outcomes, Hagger and Orbell’s meta-analysis also revealed 
individuals with strong illness identities, perceptions of less personal control, a more 
chronic timeline and most severe consequences of having the illness had the worst 
psychological health and social and role functioning and the highest psychological 
distress. Conversely, individuals who perceived their illness to be more 
curable/controllable were those with the highest sense of wellbeing and vitality. The 
relationship between illness representations and psychological functioning remained 
even after controlling for socio-demographic and disease related predictors.  
 
Interestingly, when it was published in 2003, Hagger and Orbell’s meta-analysis 
included only one cancer study and this was a study of individuals at risk of breast 
cancer who did not have a diagnosis (Rees et al., 2001). However, since 2003, 
significantly more studies have investigated the relationship between illness 
representations and the psychological health of individuals with breast cancer (Rozema, 
Vollnick, & Lechner, 2009), oesophageal cancer (Dempster M. , McCorry, Brennan, 
Donnelly, & Murray, 2012), lung cancer (Kaptein, Yamaoka, Snoei, Kobayashi, & 
Uchida, 2011), gynaecological cancer (Gould et al., 2010), prostate cancer (Traeger, 
Penedo, Dahn, & Lechner, 2009) and head and neck cancer (Llewellyn, McGurk, & 
Weinman, 2007).  
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1.5. Review aims and benefits 
Kitchenham (2004) recommends that a systematic review process identifies the need for 
a review. Despite a significant increase in the number of studies which have explored 
the association between illness representations and psychological health of adults with 
cancer over the last 10 years, there has to date been no published review attempting to 
collate and synthesise these findings
1
. The few reviews which have explored the illness 
representations of individuals with chronic illness have not focussed on or rarely 
included studies of cancer patients (Hagger & Orbell, 2003; Kaptein et al., 2008; Petrie 
et al., 2007). The Hagger and Orbell (2003) review of illness representations in 
individuals with chronic illness included only one study on cancer patients. This is 
potentially due to the possibility that the revision of the IPQ in 2002 (IPQ-R; Moss-
Morris, et al., 2002) resulted in an increased interest in exploring illness representations 
in general.  
 
To represent an original contribution to this field of research, the first objective of these 
two reviews is to identify, collate and synthesise empirical evidence which has explored 
the prospective relationship between the illness representations and the psychological 
health of adults with cancer. Exploring the predictive nature of this relationship as 
opposed to the cross-sectional correlational relationship would be more beneficial to the 
objective of the second review which is to identify and examine studies that have 
developed interventions to modify illness perceptions (directly or indirectly) to improve 
psychological health.  
 
Identifying the specific relationship between a patient’s illness perceptions at one point 
in time (or how their illness perceptions change over time) and their future 
psychological health will be extremely useful information for health care professionals 
working within oncology settings to better identify which patients might struggle to 
cope over time after receiving a cancer diagnosis. This knowledge may also be useful 
for clinicians working within clinical and health psychology, to develop appropriate 
interventions that target specific illness perceptions to reduce the likelihood of 
maladaptive coping and poor psychological health in the future. 
 
                                                 
1 This was still the case at the time data searches had all been complete and the majority of this thesis had been 
written. The author has since become aware of a very recently published review and meta-analysis of studies 
exploring the relationship between illness perceptions of adults with cancer and illness outcomes including 
psychological health (Richardson, Schuz, Sanderson, Scott, & Schuz, 2016). 
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Ultimately, there are also wider gains of these reviews which include improved 
clinician-patient communication, improving access to psychological services (by 
increasing clinician’s awareness of why some patients may disengage from therapy or 
treatment for example) and using the findings to improvement illness outcomes, 
psychological health and quality of life. Finally, a published review of this kind is likely 
to be highly read and well cited. Hagger and Orbell’s review on illness representations 
in chronic illness published in 2003 has been cited more than 1000 times. There have 
been no reviews of this kind since this time in any clinical population of patients 
meaning the impact in the clinical and academic population is greater than for a single 
study.  
 
 
1.6. Research questions 
Reviews 1 and 2 aim to answer four research questions and are as follows: 
 
 
 
 
Research questions 1 and 2 are designed to understand the prospective relationship 
between illness perceptions and the psychological health of adults with a cancer 
diagnosis and will be addressed by Review 1. In this way, a clearer understanding might 
Review 1: The prospective relationship between illness representations and 
future psychological health 
 
1. Are illness representations prospectively associated with future psychological 
health in adults with cancer? 
 
2. Which illness perceptions best predict psychological health? 
 
Review 2: Modifying illness representations to improve psychological health 
 
3. What interventions have been developed to directly or indirectly modify illness 
representations for adults with cancer? 
 
4. To what extent are these interventions effective in improving psychological 
health and modifying illness representations? 
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be gained for the role for illness perceptions as a modifiable target for interventions to 
improve the psychological health of cancer patients. Research questions 3 and 4 aim to 
improve awareness of the different ways in which illness perceptions can be modified 
and to evaluate the extent to which such interventions have been effective in improving 
psychological health outcomes over time and will be addressed by Review 2. 
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2 
METHODS 
 
 
2.1. Design 
This research used systematic review methods to answer four research questions (see 
section 1.7). Two systematic reviews were conducted.  Review 1 explored the 
prospective relationship between illness perceptions and the psychological health of 
adults with cancer. Review 2 explored studies that had carried out interventions to 
modify illness perceptions to improve psychological health. Methods of systematic 
review differ from narrative or scoping reviews in the explicit process of data extraction 
and literature searching using published guidelines to ensure all available and relevant 
data is identified and thus reducing the potential for bias. This makes the process of 
searching, including and excluding studies, evaluating, appraising and synthesising the 
literature both rigorous and replicable (Garg, Hackam, & Tonelli, 2008). Systematic 
review methods also allow researchers to suggest areas for further investigation where 
gaps in current research are identified, aim to make available evidence more 
‘accessible’ to clinicians and decision-makers and are known to provide more accurate 
reflection of the primary research than other types of review (Centre for Reviews and 
Dissemination, 2009).  
 
 
2.2. Review guidelines 
Best practice guidelines for systematic reviews developed by the Centre for Reviews 
and Dissemination
2
 (CRD: 2009) were followed to search for literature and report 
evidence, ensuring consistency and transparency in this process.  These guidelines will 
from this point be referred to as ‘CRD guidelines’. By following these rigorous 
guidelines, it was anticipated that several forms of potential selection bias could be 
attenuated (Crowther, Lim, & Crowther, 2010; Kitchenham, 2004).  Review methods 
                                                 
2
 The CRD was established in 1994 and is part of the National Institute for Health Research (NIHR). Based at the 
University of York, it is one of the largest groups in the world undertaking systematic reviews to synthesize and 
evaluate the research evidence on health and public health questions of national and international significance. CRD 
produces guidelines for researcher conducting systematic reviews in health care research 
(http://www.york.ac.uk/inst/crd/index.htm). 
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and findings are reported using the PRISMA Statement checklist
3
 as a guide (Preferred 
Reporting Items for Systematic Reviews and Meta-analyses; Moher, Liberati, Tetzlaff, 
& Altman, 2009) to improve the inclusivity of reporting and the likelihood of 
publication (McLeroy, Northridge, Balcazar, Greenberg, & Landers, 2012). 
 
 
2.3. Searching, selecting and evaluating the literature 
Although two reviews were conducted, the methods employed to generate 
inclusion/exclusion criteria and develop a search strategy (Phases 1 & 2 – see below) 
were largely the same given both reviews aimed to explore the role of illness 
representations in the psychological health of cancer patients. Where this was not the 
case (e.g. year of publication), variations in search strategy will be outlined.  
 
A structured approach to searching, selecting and evaluating the literature for both 
reviews was employed using five-phases recommended within CRD guidelines; 
 
Phase 1: A priori generation of inclusion and exclusion criteria 
Phase 2: Rigorous search for literature across multiple sources 
Phase 3: Standardized abstract screening and study selection  
Phase 4: Data extraction and standardized critical appraisal 
Phase 5: Evidence synthesis 
 
 
2.3.1. Phase 1: Generation of inclusion and exclusion criteria 
As recommended by CRD guidelines, a broad preliminary scoping search (before the 
‘review proper’) was carried out to enable the review author (the candidate) to become 
acquainted with the literature, to explore whether any similar systematic reviews existed 
and to assist in the development of inclusion/exclusion criteria. This type of early search 
has been identified as an important process in the development of inclusion criteria 
since it gives a broad overview of the size and nature of the evidence base (Popay, 
Roberts, Sowden, Petticrew, & Arai, 2006). Reviewers can then use this knowledge to 
determine how much research there is to review and what is achievable and of interest 
within the constraints of the study.  
                                                 
3 The PRISMA Statement checklist was developed by the PRISMA group in 2005 (an international committee of 
authors, methodologists, clinicians and researchers) to assist authors in improving the reporting of systematic reviews 
and meta-analyses. 
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The scoping search was conducted using the following broad search terms; illness 
representations / illness perceptions / illness cognitions / common sense model AND 
psychological health AND cancer / oncology. These terms were entered into two 
generic search engines (e.g. Google Scholar, Web of Knowledge). The scoping review 
led to the generation of a set of preliminary inclusion and exclusion criteria that was 
relevant for both reviews. These criteria were revised iteratively when new information 
was discovered, as recommended in the systematic review literature (Kitchenham, 
2004). 
 
Inclusion criteria 
The CRD guidelines recommend when deciding upon inclusion criteria, reviewers 
separate research questions into several key PICOS elements; (P)opulation (i.e. which 
population is the research question interested in?), (I)ntervention (what is the 
phenomenon of interest?), (C)omparators (what comparative studies are also eligible?), 
(O)utcomes (what are the primary or secondary outcomes of interest), and (S)tudy 
design (which study design will be relevant?). After familiarisation with the literature 
base during the scoping search and consensus discussion with supervisors, the following 
inclusion criteria were developed using four of the five PICOS elements (the 
comparators element was not relevant for either of these reviews and so was omitted); 
 
1. Population/participants: Adult participants (18yrs+) with any cancer diagnosis, 
past or present, were included in both reviews.  
 
2. Intervention/phenomenon of interest: Since Review 1 was aimed at investigating 
the predictive relationship between illness perceptions and psychological health, 
this review included only studies which had used a valid and reliable measure of 
illness perceptions (e.g. either the IPQ, IPQ-R or B-IPQ). These measures are 
currently the only available quantitative measures of illness perceptions which have 
repeatedly been shown to be both valid and reliable across a range of chronic illness 
settings, including cancer. 
 
For Review 2, the preliminary scoping search revealed only one intervention study 
that had made use of an illness perception measure. However, several studies were 
identified that reported illness representation interventions in cancer patients that 
had not employed an illness perception measure.  It was considered unwise to 
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exclude such studies which could provide potentially useful information for 
clinicians. For this reason, inclusion criteria for this review were broadened to 
include studies that had attempted to modify illness perceptions whether they 
administered an illness perception measure or not.  
 
3. Outcome: To improve the usefulness of the reviews within the field of clinical 
psychology, only studies that had used a valid measure of psychological health 
were included. The term ‘psychological health’ was defined by the reviewer and 
supervisors as ‘distinct from physical health and physical functioning outcomes; 
relating to the psychological wellbeing, mental health, level of distress, affect, or 
psychological functioning of an individual’. This definition was considered broad 
enough to capture a wide range of relevant papers which might be useful in the 
field of clinical psychology. A judgement was made by the primary reviewer and 
supervisors (for five randomly selected studies) about whether the measure 
administered represented psychological health based on this definition. For studies 
from which it was not clear whether they had used a psychological health measure 
from the paper, the complete measure was obtained and a judgement made on the 
eligibility between the primary reviewer and supervisors using Dolan’s definition. 
For both reviews, where studies used quality of life measures, only those that 
reported data on psychological health subscales were eligible for inclusion. It was 
anticipated that this would help to reduce the potential for bias when synthesising 
the data and interpreting the findings.  
 
4. Study design: Using Kitchenham’s (2004) recommendations as a guide, the 
following quantitative studies were considered appropriate for inclusion in both 
reviews; randomised controlled trial, quasi-randomised controlled trial, cohort 
study, concurrent cohort study, historical cohort study, interrupted time series and 
pre/post test case series.  
 
Exclusion criteria 
Using CRD guidelines, the following exclusion criteria were developed after the initial 
scoping search; 
 
1. Cross-sectional studies 
2. Qualitative studies 
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3. Unpublished/non-peer reviewed studies.  Since research has shown that 
significant results are more likely to be published (Garg et al., 2008), this 
criterion had the potential to increase the risk of publication bias. However, this 
potential is to some extent offset by the likelihood that unpublished studies, and 
other grey literature, are not peer reviewed and as such can introduce further bias 
(Crowther, Lim, & Crowther, 2010).  
4. Studies not published in the English language. Although evidence suggest this 
may represent a potential source of selection bias (Gregoire, Derderian, & Le 
Lorier, 1995), it was not possible to include studies which required translation 
within the time and resource constraints of this research. 
5. Studies reporting only the illness perceptions of individuals other than the person 
with cancer (e.g. carers/spouses/health care professionals).  
6. Studies reporting only an outcome measure of coping (without psychological 
health). 
7. Studies reporting only global quality of life scores rather than 
psychological/emotional/affective subscales. 
8. Studies of patients without a cancer diagnosis such as those undergoing genetic 
or other types of cancer screening or unaffected healthy individual’s perceptions 
of receiving a cancer diagnosis in the future 
9. Review papers/opinion papers/dissertations/letters to the editor 
 
 
 
2.3.2. Phase 2: Search for literature 
Generating search terminology 
CRD guidelines suggest the preliminary scoping review can be useful in developing a 
comprehensive list of key words relevant to each of the identified ‘elements’ of research 
questions (see section 2.2.1.) to construct a comprehensive search strategy for 
identifying research evidence. This list comprises keywords commonly cited in relevant 
articles, synonyms, abbreviations and spelling variants. It is suggested that final review 
search terms should be sensitive enough to identify all available relevant articles and 
specific enough to exclude irrelevant articles which can hamper the search process.  
This process should be iterative and several attempts should be made to develop a 
comprehensive strategy (Kitchenham, 2004).  Generation of search terms for each of the 
four PICOS elements will be described here. These terms were used for both reviews 
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(for an example of the search terms and truncations used within the database MEDLINE 
see Appendix II): 
 
1. Population/participants - The Macmillan cancer support website 
(www.macmillan.org.uk/Cancerinformation/ Cancertypes/AtoZ.aspx) was used to 
generate a comprehensive list of 59 cancer search terms. The inclusion criteria ‘adults’ 
was not incorporated within this element using search term parameters but applied 
manually when reviewing the extracted papers. The search terms developed were 
‘cancer’ (prefixed by 37 variants of cancer), ‘neoplasm’, ‘malignant’, ‘oncology’, 
‘tumour’ (prefixed by 5 types of tumour), ‘sarcoma’, ‘carcinoma’, ‘leukaemia (prefixed 
by 4 types of leukaemia), ‘lymphoma’, ‘lymphoblast’, ‘mesothelioma’, ‘myeloma’ and 
‘pseudomyxoma’. 
 
2. Intervention/Phenomenon of interest -  Search terms were ‘illness perceptions’, 
‘illness representations’, ‘illness cognitions’, ‘illness perception questionnaire’, ‘IPQ’, 
‘self-regulation/regulatory model/theory’, ‘illness attributions’, ‘common sense model’, 
‘causal attributions’, ‘illness identity’, ‘illness coherence’, ‘emotional representations’ 
and ‘cognitive representations’. For Review 1, only studies using one of the three illness 
perception measures (IPQ/IPQ-R/B-IPQ) were extracted.  
 
3. Outcome - The preliminary scoping search revealed a wide variation in the 
terminology used to describe and measure psychological health. A list of search terms 
was generated using definitions described within several review papers, discussion 
papers and other articles (Gomez, Gutierrez, Castellanos, Vergara, & Pradilla, 2010; 
King, Hicks, Krull, & Del Gairo, 2006; Moss-Morris et al., 2002; Ryff, 1989; Warr, 
2012) and terms used within psychometric measures of psychological health and 
wellbeing (McMillan, Bradley, Gibney, Russell-Jones, & Sonksen, 2006; Tennant et al., 
2008). The search terms developed were ‘distress’, ‘stress’, ‘wellbeing’, ‘adjustment’, 
‘adaptation’, ‘recovery’, ‘psychological’, ‘functioning’, ‘quality of life’, ‘emotional’, 
‘mental health’, ‘psychosocial’, ‘anxiety’, ‘depression’, ‘mood’, ‘coping’, ‘worry’ and 
‘affect’.  
 
4. Study design - It may have been possible to generate a list of relevant search terms 
for this facet such as observational study, randomised controlled trial, cohort study, for 
example.  However, it was decided that these terms would add little to the overall search 
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strategy and may in fact represent too stringent a filter. Therefore, study design 
characteristics were manually searched by reading titles and abstracts in the first 
instance and full papers for those studies which met additional criteria.  
 
Developing the search strategy 
CRD guidelines recommend searching a broad range of sources to maximise 
identification of relevant articles and to reduce the risk of selection bias. The following 
relevant sources were identified for both reviews and applied in the order presented 
below; 
 
1. Electronic searches – searching electronic databases comprised the largest part of 
the search strategy and was the most time intensive search. Databases a-d were 
searched via the search engine Ovid and Web of Knowledge was searched 
separately; 
a. MEDLINE 
b. AMED (Allied and Complementary Medicine)  
c. HMIC (Health Management Information Consortium) 
d. PsychINFO 
e. Web of knowledge 
 
2. Individual journal search – The initial scoping search revealed several journals 
which had published relevant material and which may have contained studies not yet 
included and indexed by electronic databases. The following journals were searched 
online between November 1980 and November 2015; 
a. Psycho-Oncology 
b. Health Psychology 
c. Psychology & Health 
d. Psychosomatic Medicine 
e. Journal of Health Psychology 
f. British Journal of Health Psychology 
g. Journal of Psychosomatic Research 
h. British Journal of Cancer 
i. Psychology, Health and Medicine 
j. Journal of Psychosocial Oncology 
 
3. Review articles – References and citations of extracted review articles were also 
searched.  
  
4. Reference lists - All relevant articles retrieved and potentially eligible for inclusion 
were searched for any additional citations and references of articles which previous 
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search techniques had not already retrieved. 
 
5. Citations –  The search engine Google Scholar™ was used to search eligible studies 
for other relevant studies that had cited their work. 
 
6. Author search – Once all eligible studies had been identified, all authors on each 
paper were searched in Google Scholar™ to determine whether they had written and 
published additional papers not yet identified. These authors were also contacted by 
email and asked a) whether they had published any work not already identified by 
the reviewer which might be eligible for inclusion and b) to provide details of any 
ongoing work pending publication. This has been identified as a good method of 
reducing the likelihood of publication bias (Kitchenham, 2004). All authors replied 
and no further papers were identified. 
 
 
The search process 
For both reviews, electronic searches were conducted first using key search terms in the 
Ovid database. It became apparent that this search engine searches titles, abstracts and 
keywords only as a default. This was manually overridden to enable a more 
comprehensive search of all fields. Non-English papers were excluded and the findings 
were de-duplicated.  
 
It is important to delineate here between papers which were relevant for Review 1 and 
those for Review 2 in terms of publication dates. Since Review 1 sought studies which 
had used a standardized measure of illness perceptions (either the IPQ, IPQ-R or B-
IPQ), studies published before 1996 when the original IPQ was developed, would be 
excluded. Since Review 2 would include studies that had employed an illness 
representation intervention but not necessarily used an illness perception measure, 
studies published before 1996 were still relevant. For this review, the search included all 
studies published between 1980, when Leventhal first proposed the common-sense 
model (Leventhal, Meyer, & Nerenz, 1980) and November 2015 (extraction date cut-
off).  
 
The number of papers found at each stage of both electronic and other searches and 
after filters were applied will be outlined in Chapter 3. It was decided that searching 
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would cease once all specified relevant databases, bibliographies and other relevant 
sources had been searched/contacted as is common in systematic reviews, particularly in 
those which are time and resource limited (Petticrew & Roberts, 2008). 
 
 
 
2.3.3. Phase 3: Abstract screening and study selection 
The CRD recommend that, once comprehensive search terms and a thorough strategy 
has been developed, a two-step approach to study selection is followed to minimize the 
risk of errors and bias. Step 1 involved the preliminary screening of all titles and 
abstracts by the primary reviewer as per inclusion and exclusion criteria. It is 
recommended that citations are initially reviewed independently and in duplicate by at 
least two reviewers at this stage to reduce the risk of incorrectly discounting or 
overlooking relevant papers (Garg et al., 2008). This was not feasible within the 
constraints of this study for either review. However, to mitigate the risk of selection 
bias, four studies extracted in the early stages of the review were chosen at random and 
discussed with supervisors in terms of the search strategy and validity of the inclusion 
criteria. Only studies which clearly did not meet inclusion criteria were rejected at this 
stage. Any studies from which it was unclear from the abstract whether inclusion 
criteria had been met were then extracted for full review in step 2. 
 
Step 2 involved the full review of potentially eligible studies which appeared to meet 
inclusion criteria based on information provided in the abstract. Studies from which a 
decision could not be made from the title and abstract alone were obtained in full for 
more detailed review. To improve selection reliability, studies for which it was 
ambiguous whether inclusion criteria had been met were discussed with supervisors to 
reach a consensus. Disagreements between reviewers (primary reviewer and two 
supervisors) were discussed and resolved by group consensus referring to inclusion 
criteria. Microsoft Access software was used to record citations of studies excluded in 
Stage 1 and those obtained in full or excluded in Stage 2, along with details on decisions 
and comments made for those papers which involved a more complex selection process. 
 
It is worth noting here that step 1 of both reviews revealed multiple studies from the 
same authors which appeared to report data from the same participant group and as such 
was identified as a potential source of bias. Although it became apparent in step 2 after 
31 
 
reading the full articles that there were multiple reasons for this (e.g. reporting different 
outcomes, adding follow up data etc.), the CRD caution against treating such studies 
separately within a systematic review which can lead to overestimation of the overall 
efficacy of effects. In cases where it was unclear whether multiple studies referred to the 
same sample of participants, first authors were contacted by email to gain a clearer 
understanding of which studies reported data from the same sample and which were the 
‘best fit’ of the inclusion criteria as recommended by DRC guidelines (see Figure 2 for 
the number of papers excluded on this basis). 
 
 
 
2.3.4. Phase 4: Data extraction and critical appraisal 
Data extraction 
This part of the reviews involved extracting and documenting relevant information from 
each extracted paper necessary to answer each of the four research questions. Using 
CRD guidelines and advice from supervisors, data extraction forms were designed to 
collate this information for each review (see Appendices III & IV for data extraction 
forms). For each review, a pilot review on two articles was carried out to address the 
completeness of forms and any usability issues (e.g. clarity and relevance of items). 
CRD guidelines recommend that ideally, data extraction should be performed 
independently by two or more reviewers (Kitchenham, 2004) to improve reliability. 
This was not possible due to time and resource constraints. Instead, supervisors were 
asked to perform data extraction using the forms on one (each) randomly selected 
studies from each review. Results were cross-checked with the primary reviewer until 
consensus was reached.  
 
Critical appraisal: Assessing study and reporting quality 
Assessing the methodological quality of studies is an important measure of the strength 
of the evidence being reviewed and highlights the extent to which synthesised findings 
are generalizable. Furthermore, this form of critical appraisal has been recognized as an 
essential step in identifying factors which could bias empirical results and thus the 
overall conclusions drawn (Kitchenham, 2004). Four common types of bias which could 
potentially affect the validity of research findings extracted for this review include 
selection bias (the difference between the comparison groups in terms of treatment 
received), performance bias (the difference in conduct of comparison groups other than 
treatment/intervention), measurement bias and attrition bias (the differences between 
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comparison groups in relation to withdrawals or exclusions of participants from 
samples).  
 
Both reviews involved the synthesis of studies with several different study designs. In 
the absence of a ‘gold standard’ critical appraisal tool for assessing multiple study 
designs (Katrak, Bialocerkowski, Massy-Westropp, Kumar, & Grimmer, 2004), a 17-
item study appraisal tool was developed to aid the evaluation of material using 
collective guidance from a number of sources (e.g. CRD: www.casp-uk.net
4
; EPPI-
Centre
5
: Harden, Oakley, & Oliver, 2001; Rees, Harden, Shepherd, Brunton, & Oliver, 
2001; Thomas, Sutcliffe, Harden, Oakley, & Oliver, 2003). These items were chosen to 
provide the most relevant assessment of methodological quality for studies included in 
both reviews (See Appendix V for items). Each criterion could be answered by placing 
a tick in one of four columns; ‘Yes’ (meeting the criteria), ‘No’ (not meeting the 
criteria), ‘Partly’ (partially meeting the criteria), and ‘Not applicable’.  
 
One notable limitation to the assessment of methodological quality is that studies do not 
always report sufficient information to determine whether criteria have been met. In 
cases such as this, there is a risk of assuming that if this information was not reported 
then it has not been collected. In studies where important information is missing which 
might allow a more thorough assessment of methodological quality, CRD guidelines 
recommend contacting lead authors to clarify missing criterion. This was not feasible 
given the time limited nature of this research. For this reason, studies in each review 
were also assessed in terms of the clarity in which relevant information was reported, 
using 16 criteria designed to assess the level and quality of overall reporting based on 
good reporting practice guidance (CRD, 2009: see Appendix VI for items). For each of 
these criteria a judgement was made about the clarity of reporting across four options; 
‘Yes’ (clearly reported), ‘No’ (not clearly reported), ‘Partly’ (the criteria was partly 
reported but not in sufficient detail to receive a ‘Yes’ judgement) and ‘Not Applicable’.  
 
The number of evident criteria (those rated with a ‘yes’ response) for both study and 
reporting quality were summed then divided by the number of applicable criteria and 
                                                 
4 The Critical Appraisal Skills Programme is part of an international network helping researchers to find and interpret 
the best available evidence from health research.  
5 The Evidence for Policy and Practice Information and Co-ordinating Centre (EPPI-Centre) is part of the Social 
Science Research Unit at the Institute of Education, University of London. The centre is dedicated to both conducting 
systematic reviews and developing review methods for social science and public policy research. 
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multiplied by 100 to generate a ‘Study’, ‘Reporting’ and ‘Total Quality’ percentage 
score for each study/paper. It is recommended (Cochrane, 2011) that this type of quality 
assessment is conducted by more than one reviewer to improve reliability of 
evaluations, and so a small sample of papers (2 from each review) were made available 
to one of the candidate’s supervisors to check they were being assessed reliably. 
Reliability between the two reviewers was good. 
 
 
2.3.5. Phase 5: Evidence synthesis 
CRD guidelines were developed predominantly to steer systematic reviews of clinical 
trials. Since the current reviews were likely to generate studies using a broader range of 
study designs, further systematic review methodology was identified to expand 
synthesis beyond simply quantifying the data as is common in systematic reviews of 
clinical trials. Findings from each study were synthesised in each review using a 
framework of narrative synthesis described by (Popay, Roberts, Sowden, Petticrew, & 
Arai, 2006). This four-stage approach recommends reviewers develop a priori theories 
about how interventions might work, develop preliminary syntheses using tables, cluster 
and content analysis, explore relationships within and between studies and acknowledge 
the robustness of the overall synthesis. Popay et al. suggest that this approach makes 
use of narrative interpretation at the synthesis stage to summarise and explain review 
findings and provides a useful alternative to simply quantifying data as is common with 
systematic reviews of clinical trials (Popay et al., 2006, pp.67).  
 
 
2.4. The potential for meta-analysis 
It is commonly understood that before meta-analysis can be carried out, findings must 
be conceptually comparable, involving the same constructs and relationships (Cochrane, 
2011). The Cochrane Collaboration recommend that meta-analyses should be conducted 
only where “participants, interventions and comparisons are judged to be sufficiently 
similar” (pp.137). There was potential to carry out a meta-analysis on a subset of 
extracted studies providing the following recommended criteria were met (Cochrane, 
2011); 
  
1. Studies used the same outcome measure of psychological health 
2. Studies used the same/comparable measure(s) of illness perceptions 
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3. There was an appropriate level of statistical reporting required to perform meta-
analysis 
4. There were at least 10 studies meeting the above criteria6 
 
Only seven studies were identified for Review 1 meaning criterion 4 was not met. For 
Review 2, data was considered insufficiently comparable to conduct meta-analysis. 
There was a wide variation in the types of cancer diagnoses (clinical diversity) and more 
so in the tools used to measure psychological health for this review. Attempting to 
quantitatively compare studies is well-known to be subjective. However, comparing 
studies with such wide diversity has been referred to as combining ‘apples with 
oranges’ (Cochrane, 2011, p.246) and can result in conclusions which are misleading 
(Garg et al., 2008). Since identified studies within both reviews did not meet criteria, 
meta-analysis of data was not possible. 
                                                 
6
 Research shows meta-analysing too few studies can mean overall review conclusions can be over-or under-
estimated (Cochrane, 2011) 
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3 
RESULTS 
 
 
3.1. Study selection 
3.1.1. Review 1 
Figure 2 below summarises the selection process for Review 1. A total of 2080 papers 
were retrieved using the electronic database search described in Chapter 2. One hundred 
and nine duplicate papers (where multiple databases had retrieved the same paper) and 
97 non-English language papers were excluded. After examination of the titles and 
abstracts of the remaining references, 1547 papers which did not match inclusion 
criteria and those which were clearly ineligible were eliminated from further analysis. 
The remaining 327 potentially relevant papers were obtained in full for further 
evaluation by the primary reviewer (the candidate) after which an additional 193 papers 
were excluded because they failed to match inclusion criteria relating to the use of 
measures. For example, some excluded studies had not included a measure of 
psychological health or illness perceptions. Others that were excluded on this basis had 
administered quality of life measures which comprised psychological health subscales 
but had reported only overall quality of life data. A total of 119 studies were also 
excluded due to designs which were not relevant (e.g. qualitative studies). Finally, eight 
studies were excluded because data reported was for the same sample in studies that had 
already been included (see section 3.2 for further information on bias). The remaining 
seven studies were considered to fit all inclusion criteria and were included in Review 1. 
Searching citations, references, individual journals (for studies not yet indexed within 
electronic databases) and contacting key authors did not retrieve any further studies that 
fulfilled eligibility criteria.  
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Figure 2: Flow diagram of study selection process for Review 1 
  
Full copies retrieved and 
assessed for eligibility 
n = 327 
Studies meeting 
inclusion criteria 
n = 7 
Total excluded n = 1753 
Not relevant subject n = 1268 
Not relevant design n = 98 
Not relevant sample n = 181       
Duplicate publication n = 109 
Foreign language n = 97 
  
 
Total excluded n = 320 
Not relevant design n = 119 
Not relevant measures n = 193 
Duplicate sample n = 8     
 
 
Studies included in Review 1 
n = 7 
No further 
studies were 
identified by any 
other means (e.g. 
citation/reference 
searching, 
individual 
journals search, 
contacting 
authors, author 
search, key 
journal search)  
 
Titles and abstracts 
identified and 
screened 
n = 2080 
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3.1.2. Review 2 
A total of 2230 papers were retrieved using the electronic database search described in 
Chapter 2. One hundred and ten duplicates (where multiple databases had retrieved the 
same paper) and 97 non-English language papers were excluded. A further 1666 papers 
were excluded because of irrelevant design, subject or sample. The remaining 357 
potentially relevant papers were obtained in full for further evaluation by the primary 
reviewer (the candidate) after which an additional 199 papers were excluded because 
they failed to match inclusion criteria relating to the use of measures. Some excluded 
studies had not used an appropriate measure of psychological health or had 
administered and reported overall quality of life data rather than specific psychological 
health measures or subscales. A total of 141 studies were also excluded due to designs 
which were not relevant (e.g. qualitative studies). Finally, eight studies were excluded 
because data reported was for the same sample in studies that had already been included 
(see section 3.2 for further information on bias). Searching citations, references, 
individual journals (for studies not yet indexed within electronic databases) and 
contacting key authors retrieved four additional studies that fulfilled eligibility criteria. 
In total, 13 studies (10 papers) were considered to fit all inclusion criteria and were 
included in Review 2. Studies will be referred to throughout this review by their 
corresponding number (e.g. 1-7 for Review 1 and 8-20 for Review 2) for ease of 
understanding (see 3.2. for key to papers and references).  
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Figure 3: Flow diagram of study selection process for Review 2 
 
  
Full copies retrieved and 
assessed for eligibility 
n = 357 
Studies meeting 
inclusion criteria 
n = 9 
Total excluded n = 1873 
Not relevant subject n = 1366 
Not relevant design n = 99 
Not relevant sample n = 201       
Duplicate publication n = 110 
Foreign language n = 97 
  
 
Total excluded n = 348 
Not relevant design n = 141 
Not relevant measures n = 199 
Duplicate sample n = 8     
 
 
Studies included in the review 
n = 13 (11 publications) 
Studies identified 
by other means 
(e.g. 
citation/reference 
searching, 
individual 
journals search, 
contacting 
authors, author 
search, key 
journal search) 
n = 4 
  
 
Titles and abstracts 
identified and 
screened 
n = 2230 
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3.1.3. Potential bias in study selection 
As previously noted in Chapter 2, there were aspects of the data search and extraction 
process that had the potential for introducing bias. For example, including only peer 
reviewed published primary studies could have increased the risk of publication bias, 
since research has shown that studies yielding significant findings are more likely to be 
published than those yielding non-significant findings (Song, Eastwood, Gilbody, 
Duley, & Sutton, 2000). Furthermore, relevant unpublished (non-peer reviewed) studies 
were excluded which could have introduced selection bias. This may mean that the 
overall significance drawn from the findings in both reviews represents an over- or 
under-estimation of the actual significance.  
 
However, since completing the current review, Richardson et al., (2016) published a 
systematic review of the overall relationships (including cross-sectional) between illness 
representations, coping and illness outcomes in adults with cancer with similar research 
objectives and an almost identical search strategy to Review 1 but included published 
non-peer reviewed ‘grey literature’ such research dissertations. Richardson et al. 
identified only one study (a doctoral dissertation) not included by the current review but 
which would have met all other inclusion criteria (Gibbons, 2013). This doctoral 
dissertation was in fact identified in the search process of Review 1 as potentially 
relevant and the author was contacted by the candidate to ascertain whether there was a 
peer-reviewed publication pending - which there was not, meaning it was excluded from 
further analysis. The significant efforts made within the search strategy to attenuate this 
potential for bias by contacting key authors to check if any studies were in progress, due 
to be published or which had been completed but not published was considered enough 
to minimize the risk of publication bias in this review. The potential for sample bias was 
also minimised by the removal of eight studies in both Reviews 1 and 2 which reported 
data on duplicate samples. These studies were those that had published data for the 
same participants in the same study that either differed in terms of reported outcome 
measures, focus of the study or the point of data collection (e.g. cross sectional vs. 
prospective follow up).  
 
A further potential source of selection bias in Review 1 was the inclusion of only 
studies which had administered the IPQ, IPQ-R or the B-IPQ. However, given that these 
are the only available psychometrically valid and reliable quantitative measure of illness 
perceptions and as such has been widely used in health settings, the risk of bias was 
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considered negligible. In a further effort to attenuate the risk of selection bias, the search 
strategies for both reviews was specifically designed to retrieve studies using a wide 
range of terminology to represent psychological health. 
 
 
3.2. Review 1: The prospective relationship between illness representations and 
psychological health 
 
3.2.1. Descriptive synthesis 
The seven studies meeting inclusion criteria for this review were published between 
2005 and 2015 and explored the prospective relationships between illness 
representations and future psychological health in adults with a cancer diagnosis. Table 
1 below provides a key for reviewed studies for reference throughout this chapter. 
 
 
Table 1: Key to papers in Review 1 
 
Study 
# 
Primary 
author 
Title 
1 
Dempster 
(2011)  
Do changes in illness perceptions predict changes in psychological distress 
among oesophageal cancer survivors? 
2 
Scharloo 
(2010)  
Illness cognitions in head and neck squamous cell carcinoma: predicting 
quality of life outcome. 
3 
Cook  
(2015) 
A prospective study of the association of metacognitive beliefs and 
processes with persistent emotional distress after diagnosis of cancer. 
4 
Ashley 
(2015)   
Illness perceptions within 6 months of cancer diagnosis are independent 
prospective predictor of health-related quality of life 15 months post-
diagnosis. 
5 
Llewellyn 
(2007)  
Illness and treatment beliefs in head and neck cancer: Is Leventhal’s 
common sense model a useful framework for determining changes in 
outcomes over time? 
6 
McCorry 
(2013)  
Illness perception clusters at diagnosis predict psychological distress 
among women with breast cancer at 6-months post diagnosis. 
7 
Millar 
(2005)  
A 1-year prospective study of individual variation in distress, and illness 
perceptions, after treatment for breast cancer. 
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3.2.1.1. Study characteristics 
Design 
All studies were questionnaire-based repeated measures prospective observation studies. 
All participants were recruited through outpatient cancer clinics with one exception 
(Study 1 used a patient support group database to recruit participants). All but Study 2 
(conducted in the Netherlands) were carried out in the UK. 
 
Clinical setting 
Although the search strategy included over 40 different cancer types, included studies 
sampled patients from only five cancer fields: breast (3, 4, 6 & 7), prostate (3 & 4), head 
and neck (2 & 5), oesophageal (1) and colorectal (4). Most patients in the entire sample 
(57%) had a breast cancer diagnosis (n=638) sampled by four out of seven studies (3, 4, 
6 & 7). The least frequent diagnosis of sampled patients was oesophageal and colorectal 
cancer (n=83). Only two studies included patients with different cancer diagnoses 
(Studies 3 & 4). 
 
Use of measures 
Papers were analysed in terms of the extent to which measures used in each study were 
both valid and reliable measures of illness perceptions and psychological health, 
acknowledging any modifications or changes in the standard or recommended 
administration of measures which have the potential to confound the findings of studies. 
  
 
1. Illness perception measures 
Administration 
Studies 1-6 used the IPQ-R to measure illness perceptions and Study 7 used the IPQ 
since its successor had not yet been published when the study was conducted. Table 2 
summarizes the components measured from the studies using the IPQ-R only. Study 7 
was excluded from this summary table because items and subscales are fewer and 
qualitatively different to those found in the IPQ-R and as such are difficult to compare 
directly.  
 
Omissions 
Of the six studies using the IPQ-R, only Study 2 administered it in its entirety (all nine 
42 
 
subscales). Remaining studies administered eight (1,3,4,6) and seven subscales (5). 
Causal items and the emotional representations subscale were most often omitted. Few 
reasons for omitting subscales were provided except for studies 3 & 4 who cited 
‘potential to cause patient distress’ (causal subscale omission) and the relative 
importance of appraising cognitive rather than emotional representations (Study 3).   
 
 
Modifications 
Only Study 4 explicitly stated the generic wording of the IPQ-R had been changed to 
make it cancer specific (e.g. “my cancer is a serious condition”) as recommended by the 
developers of the measure (Moss-Morris, et al., 2002). Two studies modified causal 
items on the IPQ-R. Moss-Morris et al., recommend the 18 causal items can either be 
analysed individually, or grouped into subscales indicated by factor analysis or based on 
theory.  Study 2 summed only causal items endorsed by more than 20% of their sample 
to form an ‘own behaviour’ 3-item subscale and while these items were highly 
correlated, factor analysis was not conducted and neither theory or evidence to support 
the existence of this subscale was reported. Study 3 combined seven psychological and 
behavioural causal items to form one subscale (‘psychological attributions’) based on 
findings from previous research (Kulik & Kronfield, 2005) but did not conduct item 
correlations or factor analysis.  
 
Table 2: Review 1 - Illness perceptions measured 
 
Illness perception 
components 
Studies measuring 
the component 
Percentage of all 
studies (n=6) 
Identity 1,2,3,4,5,6 100% 
Timeline - Acute/chronic 1,2,3,4,5,6 100% 
Timeline - Cyclical 1,2,3,4,5,6 100% 
Consequences 1,2,3,4,5,6 100% 
Coherence 1,2,3,4,5,6 100% 
Cure/control - Personal 1,2,3,4,5,6 100% 
Cure/control - Treatment 1,2,3,4,6 83% 
Cause 1,2,3,6 67% 
Emotional representations 2,4,5 50% 
 
43 
 
Scale/subscale reliability 
As recommended (Bialocerkowski, Klupp, & Bragge, 2010), Cronbach’s alpha (α) 
coefficient values (Cronbach, 1951) for IPQ and IPQ-R subscales were reported for five 
of the seven reviewed studies (2,3,4,5 & 7). Table 3 summarises these values for studies 
2-5 using the IPQ-R. Values for Study 7 which used the IPQ ranged from .72 for 
identity and cure/control subscales and .84 for the timeline subscale (n=325) but are not 
included in the summary table due to incomparable items. 
 
Table 3: Review 1 – Reliability coefficient values for illness perception subscales 
 
Illness perception 
subscales 
Cronbach’s alpha reliability coefficient 
values (α) for each study 
Range 
Study 2 
(n=177) 
Study 3 
(n=229) 
Study 4 
(n=334) 
Study 5 
(n=82) 
Identity .79 NS NS NS NA 
Timeline - Acute/chronic .86 .82 .90 .88 .82 – .90 
Timeline - Cyclical .70 .82 .77 .74 .70 – .82 
Consequences .76 NS .83 .69 .69 – .83 
Coherence .75 NS .87 .78 .75 - .87 
Cure/control - Personal .74 .64 .81 .61 .61 - .81 
Cure/control - Treatment .78 NS .82 NM .78 - .82 
Cause .80 NS NM NM NA 
Emotional representations .92 NS .89 .87 .87-.92 
NS=Not stated; NM=Not measured; NA=Not applicable 
 
It is commonly acknowledged that alpha values falling below .70 indicate less than 
acceptable internal reliability between items of that subscale: subscales with alpha 
values below .60 are considered to have poor or unacceptable internal reliability 
(Cortina, 1993). Only two studies (3 & 5) reported alpha values below .70, both for the 
personal control subscale and Study 5 for the consequences subscale. Conversely, 
subscale alpha values above .80 are considered to represent good internal reliability and 
those above .90 considered excellent. The two subscales of the IPQ-R with the best 
internal reliability were acute/chronic timeline and emotional representations, both of 
which yielded values over .80 across all four studies. 
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2. Psychological health measures 
Administration 
Five different measures of psychological health were administered by the seven studies. 
Table 4 provides a summary of each of these measures including a brief description of 
their purpose and structure.  
 
Table 4: Review 1 – Questionnaires used to measure psychological health 
 
Study 
Outcome 
measure* 
Cancer 
specific 
measure  
Validated 
in cancer 
population# 
Description 
Psychological 
health construct(s) 
measured 
1,3,5,6 HADS No Yes 
14 items measuring 
health related 
anxiety and 
depression 
Anxiety and 
depression 
2 QLQ-30 Yes Yes 
30 items across 9 
subscales measuring 
quality of life in 
cancer patients  
Emotional 
functioning 
(1 subscale - 4 items) 
3 IES No Yes 
15 items across 2 
subscales measuring 
subjective distress  
Distress 
4 
QLACS 
 
Yes Yes 
47 items across 7 
generic and 5 cancer 
specific subscales 
measuring health 
related quality of life 
in cancer patients 
Positive affect (4 
items); negative 
affect (4 items); 
distress over 
recurrence (4 items); 
family-related 
distress 
(3 items) 
5 SF-12 No No 
12 items across 8 
domains measuring 
mental and physical 
health 
Mental health 
(12 items) 
7 GHQ No No 
28 items across 4 
subscales measuring 
emotional distress in 
medical settings 
Emotional distress 
HADS - Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983); QLQ-30 – Quality of Life Questionnaire 
(Sherman, Simonton, Adams, Vural, & Owens, 2000); IES – Impact of Event Scale (Horowitz, Wilner, & Alvarez, 
1979); QLACS – Quality of Life in Adult Cancer Survivors (Avis, et al., 2005); SF-12 – Short form health survey 
(Ware, Kosinski, & Keller, SF-12: An even shorter health survey, 1996); GHQ – General Health Questionnaire 
(Goldberg & Williams, 1988); # As reviewed in Vodermaier, Linden, & Siu, 2009. 
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The most commonly administered measure of psychological health was the HADS, 
measuring anxiety and depression and was used by four studies.   Only Studies 3 and 5 
administered more than one measure of psychological health. Studies 1, 3, 5, 6 and 7 
administered specific measures of psychological distress (HADS & GHQ). Studies 2 
and 4  used broad quality of life measures which incorporated affective, psychological 
distress or emotional functioning subscales. Although only two of the six measures 
administered were cancer specific (QLQ-C30 & QLACS), two additional non-cancer 
specific general measures of distress (HADS & IES) have shown good psychometric 
properties within cancer populations (Vodermaier, Linden, & Siu, 2009). 
 
Omissions & modifications 
No studies reported modifying any psychological outcome measures or omitting any 
subscales or items. 
 
Scale/subscale reliability 
Four of the seven studies provided data on the internal reliability of their psychological 
outcome measures or subscales. Table 5 summarises reported values. These were within 
the good-excellent range of internal consistency (Cronbach, 1951).  
 
 
Table 5: Review 1 – Reliability coefficient values for psychological health 
measures  
 
Psychological health measure 
Cronbach’s alpha reliability coefficient 
values (α) for each study 
Study 3 
(n=229) 
Study 4 
(n=334) 
Study 5 
(n=82) 
Study 7 
(n=325) 
HADS 
Depression .84 NA .81 NA 
Anxiety .88 NA .89 NA 
IES .90 NA NA NA 
QLACS 
Negative feelings NA .89 NA NA 
Positive feelings NA .94 NA NA 
Distress over recurrence NA .90 NA NA 
Family related distress NA .88 NA NA 
GHQ NA NA NA .82 
NA=Not applicable 
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Procedure 
The point at which patients completed baseline and follow up measures varied widely 
between studies. Table 6 summarises the time between receiving a cancer diagnosis or 
commencing/ending treatment and completion of measures for each study.  
 
Table 6: Review 1 – Time between diagnosis/treatment and completion of 
measures 
 
Study 
Time between pre-
intervention 
baseline measures 
and diagnosis 
Time between pre-
intervention 
baseline measures 
and treatment 
cessation 
Number 
of follow 
ups 
Time between 
pre-intervention 
baseline and final 
follow up 
measures 
1 4 years (median) ‘Post-surgery’ 1 NS 
2 
‘During diagnostic 
testing’ 
‘Pre-treatment’ 2 24 months 
3 ‘Soon after diagnosis’ ‘Pre-treatment’ 1 12 months 
4 3.5 months (mean) NS 1 12 months 
5 ‘Newly diagnosed’ ‘Pre-treatment’ 2 6-8 months 
6 
1-2 weeks after 
diagnosis 
‘Post-surgery’ 1 6 months 
7 NS 7-10 days post-surgery 3 12 months 
NS=Not stated; *= Where exact time values were not reported, specific phrases used to describe the time point have 
been used as a proxy. 
 
 
Completion of baseline measures 
The exact time between patients receiving a cancer diagnosis and the completion of 
baseline measures was only provided by three studies (1, 4 & 6); this varied hugely 
from 1-2 weeks to a median of 4 years’ post diagnosis. The time between receiving 
treatment and completion of baseline measures also varied across the studies. For 
example, while three studies reported baseline measures were administered around the 
time of diagnosis before patients had undergone any form of treatment, patients in 
Studies 1 and 6 had undergone curative surgery at the point of baseline. Study 7 did not 
provide any details on the time between baseline and diagnosis but stated measures 
were administered ‘shortly after surgery’.  
47 
 
Completion of follow up measures 
Studies administered follow up measures between 6-8 months (5) and 2 years after 
baseline (2). Three studies followed patients approximately one year after baseline 
measures had been administered. However, reporting of the administration of these 
measures was inconsistent and measured using different time point references (e.g. post-
diagnosis/treatment cessation/post baseline) making it difficult to calculate exact time 
points to make direct comparisons. Patients in all studies had undergone at least one 
form of cancer treatment at the point of administration of final follow up measures. 
Although studies tended to report the types of treatment patients had already undergone 
at final follow up, most studies did not explicitly report whether any patients were still 
undergoing any form of cancer treatment at this point. 
 
 
3.2.1.2. Patient characteristics 
Sample sizes and attrition 
It is difficult to ascertain true baseline statistics because several studies reported only 
data from patients who had completed measures at all time points and did not provide 
separate baseline data. However, taking the overall data provided by these studies into 
consideration (Table 7), there were at least 1,403 participants completing measures at 
baseline and a definite 1,223 participants completing measures in final follow ups.  
 
Table 7: Review 1 – Sample sizes and attrition 
 
 
*Studies only report data for patients who provided data at all time points and actual baseline 
figures are unknown. Final time point data has been recorded in these instances; NK=Not known 
 
Study 
Total n at 
baseline 
Total n at final 
follow-up 
Overall 
attrition (%) 
1 189* 189 NK 
2 177 95 46% 
3 206* 206 NK 
4 334* 334 NK 
5 82 50 39% 
6 90 75 17% 
7 325 274 16% 
Total 1403 1223 12.8% 
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In terms of attrition, taking only the four studies which reported both baseline and final 
follow up sample sizes, the overall attrition was 27%.  However, two of these studies 
reported attrition levels significantly higher than this at 39% (5) and 46% (2). The 
overall attrition rate of 27% is therefore likely to be an underestimation of the actual 
attrition of data and simply an artefact of the poor reporting of baseline information. 
Loss to follow-up greater than 20% could be a potential source of bias for these studies 
(Schulz & Grimes, 2002). 
 
Demographics 
Ages of participants in the entire sample ranged from 23 to 98 years old, although mean 
ages of participants in each study ranged from 57 (Study 6) to 65 (Study 1) years old. 
Most patients in the collective sample were female (62%). Two studies sampled only 
female participants (6 & 7), and the remaining five studies sampled both men and 
women. Only two studies reported patient’s ethnicity, stating between 92% (4) and 
99.7% (5) of recruited patients were Caucasian. 
 
Cancer occurrence, severity and tumour stage 
Four studies included only or mostly patients for whom this was their first cancer 
diagnosis (2, 3, 5 & 6): the remaining three studies did not report this information. In 
terms of cancer severity upon recruitment, only one study included patients who had 
metastatic cancer (Study 2, 9.6% of baseline patients). Three studies (1, 4 & 7) did not 
provide data on metastases prevalence in their sample and the remaining three studies 
(3, 5 & 6) included only patients who had no metastases. Only four papers provided 
data on participants’ cancer stage or tumour severity at the point of recruitment (2, 3, 5 
& 6). However, it is not possible to directly compare participants in terms of their 
tumour stage, due to studies using incomparable indices to measure severity. 
 
 
3.2.2. Quality assessment 
3.2.2.1. Overall quality 
Each of the seven studies were evaluated according to 14 applicable study quality 
criteria and 14 applicable reporting quality criteria (see page 34 for full description of 
the item development and rating system). Percentage quality scores for each study (the 
total number of evident criteria out of applicable criteria) are presented in Table 8 in 
descending order of score.  
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Table 8: Review 1 – Study quality, reporting quality and total quality scores 
 
Study 
Study quality 
score 
(%) 
Reporting 
quality score 
(%) 
Total quality 
score  
(%) 
3 93% 86% 89% 
2 71% 100% 86% 
4 93% 79% 86% 
5 86% 86% 86% 
7 86% 71% 79% 
6 79% 64% 71% 
1 64% 50% 57% 
 
 
 
Study quality scores ranged from 64% (1) to 93% (3 & 4) with a median score of 86%. 
Reporting quality scores ranged from 50% (1) to 100% (2), with a median score of 79%. 
Total quality scores ranged from 57% (16/28 items) for Study 1 to 93% (26/28 items) 
for Study 3 with a median of 86% across all seven studies.  Although Study 1 had the 
lowest study and reporting quality scores, it had only two criteria judged as completely 
absent; the provision of internal consistency data for measures/subscales (recommended 
as best practice in questionnaire studies; Bennett, et al., 2011) and a well defined 
research question, remaining applicable items judged as either partially evident or 
unclearly reported.  
 
 
3.2.2.2. Study quality 
Table 9 summarizes criteria judged as evident (the criteria was fulfilled within the 
study) to illustrate overall study quality for each paper. Fifty-seven percent of criteria 
(8/14 items) were judged as present in all reviewed studies (see Appendix VII for 
complete breakdown of study quality ratings for each study). All studies had referred to 
Leventhal’s common sense model as a basis of understanding. The remaining six 
criteria not met by all studies was, for the majority, partially met rather than completely 
absent. Criteria not evident in all studies but which needs to be considered further as 
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potentially introducing bias to the overall findings (and which hasn’t already been 
addressed within this chapter) will be outlined below. 
 
Table 9: Review 1 – Study quality criteria judged as evident  
 
Criterion* Studies 
Percentage 
of all 
studies 
(n=7) 
1. Based on theoretical framework 1,2,3,4,5,6,7 100% 
3. Appropriate methods used to answer research question 1,2,3,4,5,6,7 100% 
9. Use of valid and reliable psychological health measure 1,2,3,4,5,6,7 100% 
10. Recommended use of psychological health measure 1,2,3,4,5,6,7 100% 
13. Adequate length of follow up 1,2,3,4,5,6,7 100% 
14. Appropriate quantitative analysis to test hypothesis 1,2,3,4,5,6,7 100% 
15. Accurate interpretation of findings 1,2,3,4,5,6,7 100% 
16. Conclusions consistent with results 1,2,3,4,5,6,7 100% 
11. Recommended use of illness perception measure 1,3,4,5,6,7 86% 
2. Well defined research question/hypothesis 2,3,4,5,6 71% 
4. Appropriate recruitment procedure 2,3,5,6,7 71% 
5. Adequate sample size for statistical analysis 3,4,5,7 57% 
12. Acceptable internal consistency 3,4,7 43% 
17. Findings generalizable 3,4 29% 
*Criterion numbers 6, 7 and 8 were not included in Review 1 as they referred to details about interventions 
 
 
 
Recommended use of measures 
In terms of the use of illness perception measures, only Study 2 was judged as only 
partly using their measure (IPQ-R) in a recommended way, due to their inclusion of 
only causal items endorsed by at least 20% of their sample. Developers of the IPQ 
recommend that causal items should be used as a subscale as indicated either by factor 
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analysis (not conducted by Study 2) or by a priori theory (Moss-Morris, et al., 2002).  
All studies administered valid and reliable measures of psychological health in full as 
recommended. 
Adequate sample sizes 
Five studies were judged as using adequate sample sizes required for statistical analysis. 
This judgement was based upon the general recommendation that between 10-15 
participants are required per predictor in regression analysis (Field, 2013). Two studies 
did not meet this criterion due to having proportionately smaller sample sizes for the 
number of variables regressed either at baseline (Study 6) or at final follow up after high 
attrition rates (Study 2). 
 
 
Generalisability 
The criterion with the poorest quality rating was the generalisability of findings. Only 
Studies 3 and 4 were rated as having findings which were generalizable due to having 
the largest samples of both male and female participants sampled from several different 
hospitals with a large age range, different cancer diagnoses and a long follow up period. 
The remaining five studies were judged to be partially generalizable to similar patient 
groups or settings but not necessarily beyond these groups due to smaller sample sizes 
(Study 5), high levels of attrition (Studies 2, 5, 6 & 7) and lack of clinical (Studies 1, 2, 
5, 6 & 7) or demographic (Studies 6 & 7) diversity. This potential for bias is notably 
common within this type of research in specific clinical settings if only one field of 
cancer is being studied as was the case for five out of seven studies reviewed (Miller, et 
al., 2005).  
 
3.2.2.3. Reporting quality 
To avoid assuming that studies with low study quality scores were necessarily poorly 
conducted studies, but indicative of insufficient reporting of information, papers were 
analysed per the quality of information provided. Table 10 summarises criteria with 
‘Yes’ ratings (criteria which was reported to a good standard) for each paper to evaluate 
the quality of reporting (see Appendix VIII for complete breakdown of reporting quality 
ratings for each study).  The only criterion evident in all reviewed studies was whether 
papers had provided a clear description of their psychological health outcome measure. 
‘Partial’ ratings were common within all studies for some criteria such as the reporting 
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of potentially confounding variables (criterion 14) and clear descriptions of recruitment 
procedures (criterion 4). Item 4 was the most poorly reported: well reported in only 
three studies.  
 
Table 10: Review 1 – Reporting quality criteria judged as evident 
 
Criterion* Studies 
Percentage of 
all studies 
(n=7) 
7. Clear definition of psychological health measure 1,2,3,4,5,6,7 100% 
2. Clear description of sample 2,3,4,5,6,7 86% 
3. Clear description of setting 1,2,3,4,5,6 86% 
12. Strengths and limitations of study stated 1,2,3,4,5,7 86% 
13. Problems with study design reported 2,3,4,5,6,7 86% 
15. Discussion of clinical relevance of findings 1,2,4,5,6,7 86% 
16. Recommendations for clinical practice discussed 1,2,3,4,5,6 86% 
1. Clearly reported aims and objectives 2,3,4,5,6 71% 
8. Clear description of data collection 2,3,4,5,7 71% 
9. Reliability of administered measures reported 2,3,4,5,7 71% 
10. Clear description of data analysis conducted 1,2,3,4,6 71% 
11. Provision of attrition data 2,3,5,6,7 71% 
14. Potentially confounding factors reported 2,3,5,7 57% 
4. Clear description of recruitment procedures 1,2,7 43% 
*Items 5 and 6 were removed from this table since they related to the reporting of interventions 
 
 
 
 
3.2.3. Overall findings 
3.2.3.1. Results of individual studies 
 
To answer research questions, findings from each study will be summarized in Table 
11. Each study is described according to findings relating to Research questions 1 and 2. 
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Table 11: Review 1 – Summary of individual study findings 
 
 
Study 1: Dempster, et al., (2011).  Do changes in illness perceptions predict changes in 
psychological distress among oesophageal cancer survivors? 
 
Study description: Evaluated the relationship between illness perception ‘clusters’ 
(patients with similar illness perception changes over time) and changes in anxiety and 
depression over time 
Research question 1 
Are illness representations prospectively 
associated with future psychological health?  
Research question 2 
Which illness perceptions best predict 
psychological health? 
 
 Illness perception ‘clusters’ 
(determined by cluster analysis of 
illness perception change scores) 
explained 3% of the variance in 
change in anxiety over time after the 
5% variance explained by 
demographic (age & gender) and 
clinical (number of other conditions, 
months since diagnosis) variables 
had been accounted for 
 
 Illness perception ‘clusters’ 
explained an additional 4% of the 
variance in change in depression over 
time after the 1% variance explained 
by demographic and clinical 
variables had been accounted for 
 
 
 The only significant differences in 
anxiety and depression (p<.05) 
between patients was between 
illness perception Cluster’s 1 and 
3: Cluster 1 patients having 
significantly more positive 
cognitions over time and Cluster 3 
patients experiencing greater 
increases in negative cognitions.  
 
 Key illness perceptions of Cluster 
3 patients (over time): 
 
o decreasing beliefs in- 
 treatment control 
 personal control 
 illness coherence 
o increasing beliefs in- 
 cyclical nature of cancer 
 chronicity 
 severity of consequences 
 the number of symptoms 
attributed to the disease 
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Table 11: Review 1 – Summary of individual study findings (continued) 
 
Study 2: Scharloo, et al., (2010).  Illness cognitions in head and neck squamous cell 
carcinoma: predicting quality of life outcome. 
 
Study description: Measured the relationship between baseline illness perceptions 
and emotional functioning 1 and 2 years later 
 
Research question 1 
Are illness representations prospectively 
associated with future psychological 
health? 
Research question 2 
Which illness perceptions best predict 
psychological health? 
 
 Illness perceptions did not predict 
emotional functioning at either 1 or 
2 years follow up 
 
 None. Best predictor of emotional 
functioning at both 1 and 2 years 
follow-up was baseline emotional 
functioning (which explained 42% of 
variance in scores) 
Study 3: Cook, et al., (2015). A prospective study of the association of metacognitive 
beliefs and processes with persistent emotional distress after diagnosis of cancer. 
 
Study description: Measured the relationship between baseline illness perceptions 
and anxiety and depression 12 months later 
Research question 1 Research question 2 
 
 Baseline illness perceptions 
explained 3% of the variance in 
anxiety and 3% in depression 
scores 12 months later after 
controlling for age, gender, and 
baseline anxiety and depression 
(which collectively accounted for 
38% of the variance in depression 
& anxiety at T2) 
 
 Perceived lack of personal 
control predicted 1% of the 
variance in T2 anxiety 
 
 Negative perceptions of the 
consequences of cancer predicted 
2% of the variance in T2 anxiety 
 
 Poor illness coherence predicted 
3% of the variance in T2 
depression  
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Table 11: Review 1 – Summary of individual study findings (continued) 
Study 4: Ashley et al., (2015).  Illness perceptions within 6 months of cancer 
diagnosis are independent prospective predictor of health-related quality of life 15 
months post-diagnosis. 
Study description: Measured the relationship between illness perceptions measured 
within 6-months post diagnosis and affect and distress measured 15-months post 
diagnosis 
Research question 1 
Are illness representations prospectively 
associated with future psychological 
health? 
Research question 2 
Which illness perceptions best predict 
psychological health? 
 
 Illness perceptions accounted for 
18.6% of the variance in negative 
affect, 17.9% in positive affect, 
27.9% in distress over cancer 
recurrence and 10.5% in family-
related distress, after controlling 
for socio-demographic (age, 
gender, SES) and clinical 
(diagnosis, treatment received) 
variables 
 
 Socio-demographic and clinical 
variables accounted for less 
variance than illness perceptions in 
T2 negative affect (7.5%), positive 
affect (2.8%), distress over 
recurrence (10.5%) and family-
related distress (1.4%) 
 
 
 Illness identity was significantly 
predictive of T2 distress over cancer 
recurrence and family-related 
distress 
 
 Perceptions of the severity of 
consequences were significantly 
predictive of both T2 negative and 
positive affect  
 
 Emotional representations were 
significantly predictive of both 
positive and negative affect, distress 
over recurrence and family-related 
distress 
 
Study 5: Llewellyn et al., (2007).  Illness and treatment beliefs in head and neck 
cancer: Is Leventhal’s common sense model a useful framework for determining 
changes in outcomes over time? 
Study description: Measured the relationship between baseline pre-treatment illness 
perceptions and anxiety and depression 6-8 months after treatment completion. 
Research question 1 Research question 2 
 
 Baseline illness perceptions* 
predicted 28% of the variance in 
depression 6-8 months later (T3) 
 
 Baseline illness perceptions did not 
predict T3 ‘mental health’ or anxiety  
 
 
* Only illness perceptions about 
the chronicity of cancer (timeline) 
were predictive of scores in 
depression at T3 
 
 Only baseline anxiety was 
predictive of T3 anxiety and 
accounted for 27% variance 
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Table 11: Review 1 – Summary of individual study findings (continued) 
 
Study 6: McCorry, et al., (2013).  Illness perception clusters at diagnosis predict 
psychological distress among women with breast cancer at 6-months post diagnosis 
  
Study description: Measured the relationship between illness perceptions at 
diagnosis and anxiety and depression 6 months after diagnosis 
Research question 1 
Are illness representations prospectively 
associated with future psychological 
health? 
Research question 2 
Which illness perceptions best predict 
psychological health? 
 
 Illness perception ‘cluster’ 
membership predicted 9.5% of the 
variance in anxiety and 11.3% of 
the variance in depression 6 
months later (T2) after controlling 
for socio-demographic (age, no. of 
dependents, living arrangements) 
and clinical (tumour stage, 
treatment received, tumour 
severity, previous psychiatric 
input) variables 
 
 Participants in Cluster 1 had more 
negative illness perceptions overall 
and higher levels of depression and 
anxiety at T2 than participants in 
Cluster 2 
 
 Cluster 1 patients had a less 
coherent understanding of their 
illness and were more likely to 
believe their illness was chronic, 
cyclical, less controllable and 
severe, and had more associated 
symptoms and causes than patients 
in Cluster 2 
 
 Cluster analysis enabled the 
identification of an ‘at risk’ 
subgroup of women in Cluster 1 
with ‘problematic anxiety’, 
identified as potential target for 
intervention 
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Table 11: Review 1 – Summary of individual study findings (continued) 
 
 
Study 7: Millar et al., (2005).  A 1-year prospective study of individual variation in 
distress, and illness perceptions, after treatment for breast cancer. 
 
Study description: Measured the relationship between illness perceptions 7-10 days 
after surgery and psychological distress 12 months later 
Research question 1 
Are illness representations prospectively 
associated with future psychological health? 
Research question 2 
Which illness perceptions best predict 
psychological health? 
 
 Baseline illness perceptions* 
explained 5.9% of the variance in 
emotional distress’ after 12 months 
(T2) after controlling for baseline 
emotional distress (which predicted 
29% of the variance in T2 emotional 
distress) 
 
* Only illness identity predicted 
emotional distress 12 months later 
 
 
3.2.3.2. Data synthesis 
Approaches 
Three main approaches were used by the seven studies to measure the prospective 
relationship between illness perceptions and psychological health (depicted in Figure 3). 
Before attempting to synthesize outcomes and answer Research question 1, it is 
important to first outline and consider the differences in these approaches.  
 
Approach 1 
Study 1 measured illness perceptions and psychological distress at Time 1 (T1) and 
Time 2 (T2) to calculate change scores for both variables (T2 scores - T1 scores). Illness 
perception change scores were then subject to cluster analysis to group together patients 
whose illness perceptions changed in similar patterns between T1 and T2. Regression 
analysis was then used to determine the predictive relationship between clusters 
(changes in illness perceptions over time) and psychological distress change scores. 
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Approach 2 
Studies 2, 3, 4, 5 and 7 used multiple regression analysis to examine the predictive 
relationship between illness perception scores across several IPQ and IPQ-R domains 
measured at T1 and psychological health scores measured at T2. 
 
Approach 3 
Study 6 also conducted cluster analysis, but only on T1 illness perception scores to 
determine clusters of patients who shared similar patterns of illness perceptions at 
baseline. Regression analysis was then used to determine the predictive relationship 
between T1 illness perception clusters and T2 psychological distress. 
 
 
  
Figure 4: Three approaches to measuring the prospective relationship between illness 
perceptions and psychological health 
 
                             Approach 1  
                                  (Study 1) 
 
                          Illness perceptions 
T1       T2   Do changes in illness  
         Change     ‘clusters’ (patients who 
        share similar beliefs) over    
        time predict changes in      
                         Psychological health    psychological health over 
T1         T2   time? 
          Change 
                                     
 
 
 
                               Approach 2  
                          (Studies 2, 3, 4, 5 & 7) 
    T1        T2  Do illness perception  
  Illness          Psychological ‘clusters’ at T1 predict 
Perceptions         Health   psychological health scores 
        Scores at T2?                                                                                                                                                                                            
                         
 
 
 
                                Approach 3  
                                      (Study 6) 
 
T1 Illness      T2  Do illness perception  
Perception     Psychological scores at T1 predict 
‘clusters’          health  psychological health 
        Scores at T2? 
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Findings from each study varied depending on the approach used to measure the 
relationship between illness perceptions and psychological health. As the only study 
using Approach 1, Study 1 found 3% and 5% of the variance in changes in anxiety and 
depression respectively could be explained by changes in illness perceptions over time. 
Studies using Approach 2 reported between 0 (Study 2) and 28% (Study 5) of the 
variance in several psychological outcomes could be explained by baseline illness 
perceptions. Using Approach 3, Study 6 found that 9.5% and 11.3% of the variance in 
anxiety and depression respectively at T2 could be explained by illness perception 
clusters at T1.  
 
 
The strongest relationships between illness perceptions and psychological health were 
found by Studies 4 and 5. Study 4 found that illness perceptions measured within 6-
months of receiving a breast, colorectal or prostate cancer diagnosis predicted between 
10.5% and 27.9% of the variance in positive and negative affect, distress over cancer 
recurrence and family-related distress 15-months post diagnosis. This variance was over 
and above the comparatively smaller variance in the same outcomes predicted by age, 
gender, socioeconomic status, diagnosis and type of treatment received. Study 5 found 
that illness perceptions, measured pre-treatment, accounted for similarly high levels of 
the variance in depression (28%) 6-8 months after treatment cessation in a sample of 
head and neck cancer patients. However, it is unclear from the Study 5 paper whether 
this variance was in addition to those explained by sociodemographic and/or clinical 
variables since their regression was not hierarchical and the outcomes were not clearly 
reported. 
 
Several studies found comparatively less variance in psychological health could be 
explained by illness perceptions once sociodemographic and disease related variables 
had been entered hierarchically in to regression models (2, 3 & 7). For example, Study 3 
found that illness perceptions measured shortly after diagnosis accounted for 12% of the 
variance in anxiety and depression 12 months later after accounting for age and gender 
Review 1: Research question 1 
Are illness representations prospectively associated with future 
psychological health in adults with cancer? 
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but this decreased to only 3% once baseline anxiety and depression levels had also been 
considered by the regression model. Baseline anxiety and depression levels 
independently accounted for significantly more of the variance in anxiety and 
depression (25% and 21%) than illness perceptions 2 years later. Study 7 also found that 
only 6% of the variance in emotional distress could be explained by illness perceptions 
measured 12 months previously in a sample of breast cancer patients once baseline 
levels of emotional distress had been explained. In fact, baseline emotional distress in 
Study 7 was the biggest predictor of emotional distress 12 months later, accounting for 
29% of the overall variance. This was a common finding within studies that entered 
baseline psychological health variables into their regression analyses before illness 
perception variables. The largest degree of explained variance in psychological health 
was reported by authors of Study 2 who found that emotional functioning of patients 
with head and neck cancer at the point of diagnosis explained 42% of the variance in 
their level of emotional functioning 2 years later. 
 
 
 
 
This research question aimed to explore which illness perceptions were the most 
predictive of future psychological health. Since not all illness perceptions were 
measured by every study and those measured were not all independently predictive of 
future psychological health, it would first be helpful to reconsider the main approaches 
employed to measure this relationship: namely, studies that used cluster analysis and 
those that did not (see Figure 3). Studies that did not conduct cluster analysis examined 
which illness perceptions of those measured were independently predictive of 
psychological health over time. By comparison, studies which used a clustering 
approach (Studies 1 & 6) examined whether cluster membership was predictive of 
psychological health. This method assumes that all illness perceptions measured are 
predictive of outcomes: neither study reporting the predictive relationship between 
specific illness perception dimensions and future psychological health. Table 12 
provides a summary of the relationships found for all studies combined. 
Review 1: Research question 2 
Which illness perceptions best predict psychological health? 
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Table 12: Review 1 – Significant relationships matrix 
 
Illness perception 
components 
Relationship 
%* 
Study 
1 
Study 
2 
Study 
3 
Study 
4 
Study 
5 
Study 
6 
Study 
7 
Identity C - - I - C I 57% 
Consequences C - I I - C - 57% 
Coherence C - I - - C NM 50% 
Cause C - - NM NM C NM 50% 
Timeline - 
Acute/chronic 
C - - - I C - 43% 
Cure/control - Personal C - I - - C - 43% 
Cure/control - 
Treatment 
C - - - NM C NM 40% 
Timeline - Cyclical C - - - - C NM 33% 
Emotional 
representations 
NM - NM I - NM NM 33% 
C = Relationship found only as part of a cluster of illness perceptions; I = Independent relationship between illness 
perception and psychological health; NM = Not measured; - = no predictive relationship found; * = percentage of 
studies that measured the illness perception finding a significant relationship with psychological health 
 
 
 
All illness perceptions were found to be significantly predictive of future psychological 
health by at least one study.  Only one study did not find any of their measured illness 
perceptions to be significantly predictive of psychological health (2). Perceptions of 
illness identity and consequences were measured by all seven studies and were found to 
be significantly predictive of psychological health in four studies.  By comparison, 
emotional representations were the least measured dimension and found to be predictive 
of outcomes in only one study.  
 
 
Studies using cluster analysis (Approaches 1 and 3) 
Study 1 
Using Approach 1, Study 1 conducted cluster analysis to determine whether changes 
over time across all eight illness perceptions measured were predictive of psychological 
distress and found, within a sample of 189 oesophageal cancer patients, four distinct 
clusters of patients.  
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Patients identified as ‘Cluster 1’ had the most positive changes across all illness 
perceptions over time: negative illness perceptions decreased and positive perceptions 
increased between T1 and T2. Patients identified as ‘Cluster 2’ had increasing beliefs 
over time in their own ability to control their illness but decreasing beliefs that treatment 
would be effective in controlling their cancer over time.  Locus of control was thought 
to be a defining feature of this cluster. ‘Cluster 3’ patients reported the most negative 
changes in all illness perceptions over time with increasing beliefs that their illness was 
chronic, cyclical, had severe consequences with a low sense of personal and treatment 
control. Although there were similarities in the illness perceptions of Cluster 3 patients 
and patients in other clusters, the key feature of this cluster was that patients 
increasingly believed their illness could not be controlled by themselves or by 
treatment: more so than patients in any other cluster. It is suggested within the paper 
that this sense of hopelessness/helplessness may make these patients particularly 
vulnerable to poor psychological wellbeing.  
 
Finally, patients in ‘Cluster 4’ were those who attributed more symptoms to their 
condition over time, increasingly found their condition confusing but were more hopeful 
than patients in clusters 2 and 3 that it could be controlled either by themselves or with 
treatment. 
 
Study 6 
Using Approach 3, Study 6 also conducted cluster analysis, finding their sample of 90 
breast cancer patients could be categorised into two distinct groups of patients who 
shared similar illness perceptions.  Unlike Study 1, cluster membership was 
determined using only illness perceptions measured shortly after diagnosis rather than 
the degree to which perceptions changed over time. Findings revealed women in 
‘Cluster 1’ had a poorer sense of illness coherence, were more likely to believe their 
illness was chronic and cyclical, attributed more symptoms and causation to their 
illness and had stronger beliefs that it could not be controlled. Patients in this cluster 
fared less well psychologically than patients in other clusters and were more likely to 
become significantly depressed or anxious 6 months later compared to women in 
‘Cluster 2’ who had more positive perceptions of their cancer overall. 
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Studies not using cluster analysis (Approach 2) 
The remaining studies (2, 3, 4, 5 & 7) did not use a clustering approach, but more 
simply measured the degree to which scores on specific illness perceptions were 
independently predictive of future psychological health scores. Their findings will be 
presented according to each of the nine illness perception domains. 
 
Identity 
Study 4 reported that illness identity perceptions within 6 months of receiving a cancer 
diagnosis were significantly predictive of distress over cancer recurrence and family-
related distress 15-months post diagnosis in a sample of breast, prostate and colorectal 
cancer survivors. Patients who associated more symptoms with having cancer were 
more likely to be fearful their cancer would return and would report more distress over 
family related issues into long-term survivorship. Similarly, Study 7 reported that 
women who attributed more symptoms to their cancer within 2 weeks of breast cancer 
surgery were more likely to be emotionally distressed 12-months later. Interestingly, 
this was the only illness perception domain found to predict future psychological health 
in this study although it is also important to acknowledge that this study was the only 
study using IPQ which represented only five of the current nine illness perception 
domains measured by the IPQ-R. 
 
Illness coherence 
Only Study 3 found a significant independently predictive relationship between illness 
coherence and psychological outcomes. Breast and prostate cancer patients in this study 
who reported a poorer understanding of their illness shortly after being diagnosed were 
more likely to feel depressed 12 months later, after controlling for age, gender and 
baseline depression. Interestingly, illness coherence was not predictive of future anxiety 
symptoms. 
 
Timeline – acute/chronic 
Only Study 5 found an independently predictive relationship between perceptions about 
the chronicity of cancer and psychological health. Newly diagnosed patients with head 
and neck cancer who had stronger beliefs that their illness was chronic pre-treatment 
were significantly more likely to report feeling depressed 6-8 months after treatment 
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cessation. This was the only illness perception found to be predictive of depression in 
this study. 
 
Timeline – cyclical 
Other than studies using cluster analysis, there were no other studies that found illness 
perceptions about the cyclical nature of cancer to be independently predictive of future 
psychological health. 
 
Consequences 
Studies 3 and 4 found perceived consequences of having (had) a cancer diagnosis to be 
significantly predictive of future psychological health. Study 3 found that breast and 
prostate cancer patients who believed their illness would have more severe 
consequences shortly after being diagnosed were more likely to suffer anxiety 12 
months later. Study 4 reported that patients who believed their cancer would have more 
severe consequences within 6 months of receiving a diagnosis reported significantly 
worse negative affect 15-months post-diagnosis. An inverse relationship was found in 
this study between positive affect and consequential beliefs: patients who had 
perceptions their cancer had less of an impact upon themselves and others were more 
likely to report positive affect into survivorship.  
 
Cause 
Other than Study 6 that used cluster analysis, there were no other studies that found 
illness perceptions about cancer causation to be significantly and independently 
predictive of future psychological health. 
 
Emotional representations 
Of the 3 studies which measured emotional representations, only Study 4 found an 
independently predictive relationship between emotional representations and 
psychological outcomes. This study reported that breast, colorectal and prostate cancer 
patients who felt more negative about their illness within 6 months of receiving a 
diagnosis were those with the most negative affect, least positive affect and greatest 
distress over cancer recurrence and family-related distress 15-months post-diagnosis. 
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Treatment control 
Other than studies using cluster analysis, no other studies found perceptions of 
treatment control to be significantly and independently predictive of future 
psychological health. 
 
Personal control 
Study 3 found personal control to be significantly predictive of future emotional 
distress. Breast and prostate cancer patients who believed they had less personal control 
over their condition shortly after diagnosis experienced higher levels of anxiety 12 
months later than patients who believed they had more personal control over the 
disease. 
 
 
3.2.4. Review 1: Summary 
There was much methodological variability in the seven papers reviewed in Review 1, 
in terms of type and number of patients, use of measures, and the point at which patients 
were asked to complete baseline and follow up measures which may have increased the 
possibility for bias and made synthesis and between-study comparisons challenging. 
Studies used three different approaches to assessing the relationship between illness 
perceptions and psychological health which added further complexity to the synthesis of 
data. Nevertheless, six of the seven studies found at least one illness perception to be 
predictive of psychological health; some independently predictive (Studies 3, 4, 5 & 7), 
others as part of a cluster of illness perceptions (Studies 1 & 6). Variance in 
psychological health explained by illness perceptions ranged from 3% to 28% after 
socio-demographic and other disease related variables were considered by regression 
analyses. It is difficult to report definitively which illness perceptions were the best 
predictors of future psychological health due to considerable differences in 
measurement and analyses. Taking the six studies which found significant associations 
into consideration, perceptions about illness identity and the consequences of having 
cancer were the two most commonly observed predictors of psychological health. 
However, all nine illness perceptions measured were found to be significantly predictive 
of psychological health by at least one study either independently or as part of an illness 
perception cluster. Perceptions about causes, the curability/controllability and the 
timeline of cancer were only predictive of psychological health as part of a cluster of 
perceptions, as opposed to being independently predictive. 
66 
 
3.3. Review 2: Modifying illness representations to improve psychological health 
 
3.3.1. Descriptive synthesis 
The thirteen studies meeting inclusion criteria were published between 2007 and 2015. 
The studies described a range of interventions to modify illness perceptions directly or 
indirectly with a view to improving psychological health, among other illness outcomes, 
in cancer patients.  Studies will be referred to throughout this section by their 
corresponding number for ease of understanding. To avoid confusion, the following 
thirteen studies extracted for Review 2 will be numbered continuously from Review 1 
(e.g. 8-20) and a key is provided in Table 13 for ease of reference.  
 
Table 13: Review 2 - Key to papers reviewed 
 
 
Study 
# 
Primary 
author 
Title 
8 
Traeger 
(2013) 
Identifying how and for whom cognitive-behavioral stress 
management improves emotional well-being among recent cancer 
survivors 
9 
Lichtenstein 
Jorgensen 
(2009) 
An exploratory study of associations between illness perceptions and 
adjustment and changes after psychosocial rehabilitation in survivors 
of breast cancer 
10 
Fischer 
(2013) 
From despair to hope: A longitudinal study of illness perceptions and 
coping in a psycho-educational group intervention for women with 
breast cancer 
11 
Schuurs 
(2013) 
A feasibility study of group cognitive rehabilitation for cancer 
survivors: enhancing cognitive function and quality of life 
12 
King 
(2015) 
Psychological intervention for improving cognitive function in cancer 
survivors: a literature review and randomized controlled trial 
13 
Cameron 
(2007) 
Changes in emotion regulation and psychological adjustment 
following use of a group psychosocial support program for women 
recently diagnosed with breast cancer 
14 
Humphris 
(2012) 
AFTER and beyond: cancer recurrence fears and a test of an 
intervention in oropharyngeal patients 
15 
Ward 
(2008) 
A randomized trial of a representational intervention to decrease 
cancer pain 
16 
Ward 
(2009) 
A randomized trial of a representational intervention for cancer pain: 
Does targeting the dyad make a difference? 
17 
Heidrich 
(2009) 
An individualized representational intervention to improve symptom 
management in older breast cancer survivors: Three pilot studies 
18 
19 
20 
Smith 
(2015) 
Pilot of a theoretically grounded psychologist-delivered intervention 
for fear of cancer recurrence (Conquer Fear) 
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3.3.1.1. Study characteristics 
Design 
There were eight randomised controlled trials (8, 9, 12, 14 - 18), two non-randomised 
controlled trials (11 & 13) and three before/after studies (10, 19 & 20).  
 
Clinical setting 
Table 14 summarises clinical specialities and sample sizes for each clinical area.  
 
 
Table 14: Review 2 - Clinical specialties and combined dataset sizes 
 
Cancer specialty Articles 
Percentage 
of total 
studies 
reviewed 
Combined 
total N at 
final follow 
up 
Breast 9,10,11,12,13,15,16,17,18,19,20 85 556 
Prostate 8,11,12 23 219 
Haematological 12,15,16 23 20 
Lung 15,16 15 50 
Gastrointestinal 15,16 15 82 
Colorectal 11,12 15 9 
Gynaecological/ 
Genitourinary 
15,16 15 80 
‘Mixed’ 11,16 15 11 
‘Other’ 15,16 15 26 
Ovarian 11,12 15 2 
Head and neck 11 8 1 
Testicular 11 8 1 
Not stated 20 8 3 
Oral/Oropharyngeal 14 8 77 
Total N 1219 
 
 
Studies sampled patients from eleven specific fields of oncology. Four studies reported 
the inclusion of patients with unspecified diagnoses (Studies 11, 15, 16 & 20). Most 
studies (n=8) sampled patients from only one cancer specialty. One study included 
patients from two clinical areas (20), one from five areas (12), one from six areas (15) 
and two from seven clinical areas (11 & 16). The most frequent diagnosis of patients 
across the thirteen studies was breast cancer, making this the largest sample of patients 
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overall at final follow up and comprising 46% of the total sample. The least frequent 
diagnosis of sampled patients was head and neck cancer (n=1), testicular cancer (n=1) 
and ovarian cancer (n=2) and comprising of only .3% of the total sample combined. 
 
Recruitment 
Seven studies recruited only patients known to the clinic/service via current referral lists 
or waiting lists (13-16 & 18-20). The remaining six studies made use of one or more 
methods of ‘opt-in’ recruitment including hospital and community advertisement 
material such as brochures and posters (8-11 & 17), state cancer registries and mailing 
lists (8 & 12) and local cancer support groups (11 & 12).   
 
Location 
Studies were conducted within several countries worldwide including the USA (8, 15-
19), Australia (11, 12 & 20), Denmark (9), the Netherlands (10), New Zealand (13). 
Only one study was conducted in the UK (14). Most studies (62%) involved 
interventions conducted within specialist outpatient or inpatient cancer clinics or other 
rehabilitative medical centres.  
 
Measures 
Papers were analysed in terms of the extent to which measures used in each study were 
valid and reliably used, acknowledging any modifications or changes in the standard or 
recommended administration of measures which have the potential to confound the 
findings of studies. 
 
 
1. Illness perception measures 
Administration 
Only six of the thirteen studies (46%) directly measured patient’s illness perceptions 
using a quantitative measure. Four of these studies administered the IPQ-R (8, 9, 10 & 
13) and two used the B-IPQ (11 & 12). Table 15 summarizes the illness perception 
dimensions measured by each study. 
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Table 15: Review 2 - Illness perceptions measured 
 
Illness perception 
dimension measured 
Studies 
Percentage of 
studies which could 
measure the 
dimension 
Cure/control - Personal 8,9,10,11,12,13 100% 
Concern* 11,12 100% 
Consequences 8,9,10,11,12 83% 
Cure/control - Treatment 8,9,10,11,12 83% 
Identity 9,10,11,12 67% 
Timeline - Acute/chronic 9,10,11,12 67% 
Coherence 8,10,11,12 67% 
Emotional representations 9,10,11,12 67% 
Cause 8,9 33% 
Timeline – Cyclical# 10 25% 
*Only measured within the B-IPQ scale; #Could not be measured by studies using B-IPQ as this 
is not one of the subscales 
 
 
 
Omissions 
No study administered the IPQ-R or B-IPQ in their entirety (e.g. all nine 
subscales/items). Of the two studies using the B-IPQ (11 & 12), the same eight out of a 
possible nine illness perception items were administered by both studies. Neither study 
provided a reason for the omission of causal items. From the four studies using the IPQ-
R, one administered eight subscales (Study 10), one used seven subscales (Study 9), one 
used five subscales (Study 8) and Study 13 used only the personal control subscale 
since this was their main target for change. Personal control was the only illness 
perception dimension to be administered by all six studies. The least utilized subscale 
was cyclical timeline: only one of the four studies which could have administered the 
cyclical timeline subscale (the B-IPQ does not have this as an independent item) did so. 
Reasons for omission were not provided in Studies 9 and 13, while authors of Study 8 
suggested this omission, along with the omission of three other subscales was because 
they were considered “ambiguous targets for change” within their patient group (men 
over 50 years old with a diagnosis of prostate cancer). 
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Modifications 
Two of the six studies using an illness perception measure did not report making any 
modifications to administered items and subscales (Studies 10 & 11). The remaining 
four studies made several modifications. Study 8 developed a ‘composite causal scale’ 
based on previous findings. Study 9 translated the IPQ-R into Danish. Study 12 
developed two versions of the B-IPQ. The first one, designed for cancer patients, asked 
respondents to complete the measure in relation to their cognitive difficulties (as 
opposed to their cancer). The second version, developed specifically for their 
community control group of healthy individuals, asked participants to respond by 
‘imagining’ what they thought it would be like to experience cognitive difficulties. 
Study 13 used only half of the personal control subscale without reporting coefficient 
values for the three items.  
 
Scale/subscale reliability 
Only three of the four studies which administered the IPQ-R (the B-IPQ does not have 
any subscales) reported Cronbach’s alpha (α) coefficient values (Cronbach, 1951). 
Table 16 summarises these values for Studies 8, 10 and 13.  
 
 
Table 16: Review 2 – Reliability coefficient values for illness perception 
subscales 
 
Illness perception 
subscales 
Cronbach’s alpha reliability 
coefficient values (α) for each study 
8 
(n=257) 
10  
(n=74) 
13 
(n=154) 
Identity NM NS NM 
Timeline - Acute/chronic NM .88 NM 
Timeline - Cyclical NM .71 NM 
Consequences .65 .78 NM 
Coherence .83 .73 NM 
Cure/control - Personal .72 .71 .80    
Cure/control - Treatment .78 .73 NM 
Cause .68 NM    NM 
Emotional representations NM .91 NM 
NS=Not stated; NM=Not measured; NA=Not applicable 
71 
 
As reported previously, alpha values falling below .70 indicate less than acceptable 
internal reliability between items of that subscale: subscales with alpha values below .60 
are considered to have unacceptable internal reliability (Cortina, 1993). None of the 
studies reported alpha values below .60, although Study 8 reported both their 
consequences and cause subscales to have values below .70. All seven subscales 
administered by Study 8 were found to have a good to excellent internal consistency as 
was the personal control subscale administered (the only subscale of the IPQ-R 
administered) by Study 13.  
 
 
2. Psychological health measures 
Administration 
Thirteen different questionnaires were used to measure psychological health. Table 17 
provides a summary of these measures including a brief description of their purpose. 
Ten studies administered one or more measures specifically designed to assess only 
psychological difficulties such as depression (10-12, 14, 17-19), anxiety (10-14 & 17-
19), mood disturbance (9 & 19), distress (20), mental adjustment (14) and mental health 
(17-19). Four of these studies administered more than one specific measure of 
psychological health (14 & 17-19). Five studies administered measures of quality of life 
or general health which comprised several ‘functioning’ subscales including 
psychological/emotional functioning (8, 12, 13, 15 & 16). Three of these studies (8, 15 
& 16) administered a single broad quality of life measure, reporting affective or 
emotional functioning subscales, meaning psychological health was measured in as few 
as four items (8, 15 & 16). 
 
Omissions & modifications 
No studies reported modifying any psychological health measure or omitting any 
subscales or items. 
 
Scale/subscale reliability 
Only four of the thirteen studies provided data on the internal reliability of their 
psychological health measures or subscales (Studies 8, 10, 13 & 16).  The highest alpha 
value was reported by Study 10 which revealed a coefficient value of .90 for the 25-item 
Hopkins Symptom Checklist. Studies 13 and 16 reported similarly high levels of 
internal consistency for the 40-item STAI (α=.89) and the 6-item mood subscale of the 
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QLQ-C30 (α=.85) respectively.  The lowest coefficient values were reported for the 6-
item emotional wellbeing subscale of the FACT-G by Studies 8 (α=.70) and 13 (α=.66). 
These values would indicate less than acceptable internal reliability between items of 
that subscale (Cortina, 1993) and could be potentially problematic for Study 8 since this 
was their only measure of psychological health whereas Study 13 administered two 
measures: one of which had excellent internal consistency (STAI).  
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Procedure 
The point at which patients completed baseline and follow up measures varied widely 
between studies. Table 18 summarises the time between receiving a cancer diagnosis or 
ending treatment and administration of measures for each study.  
 
Table 18: Review 2 – Time between diagnosis/treatment and completion of 
measures 
 
Study 
Time between 
diagnosis and pre-
intervention 
baseline measures 
Time between 
treatment cessation 
and pre-intervention 
baseline measures 
Number 
of follow 
ups 
Time between 
pre-intervention 
baseline and final 
follow up 
measures 
8 15.5 months (mean) 10.3 months (mean) 1 3 months 
9 ‘Within last 5 years’ 12.7 months (mean) 2 6 months 
10 NS 
‘Completed curative 
treatment’ 
2 12 months 
11 57 months (mean) 42 months (mean) 2 4-5 months 
12 58 months (mean) 42 months (mean) 2 3 months 
13 
Diagnosed within last 
6 weeks 
3 weeks 3 12 months 
14 NS 3 months 2 8 months 
15 NS NS 2 2 months 
16 NS NS 2 2 months 
17 9 years (mean) NS 2 2-3 months 
18 2.7 years (mean) NS 5 4 months 
19 3.6 years (mean) NS 2 4 months 
20 2.3 years (mean) 
‘Completed curative 
treatment’ 
2 2 months 
NS=Not stated; * = Where exact time values were not reported, specific phrases used to describe the time point have 
been used as a proxy. 
 
 
 
Completion of baseline measures 
Most studies reported the time between patients receiving a cancer diagnosis and the 
completion of baseline measures (9/13). This varied hugely from less than 6 weeks 
since diagnosis (Study 13) to a mean of 9 years since receiving a diagnosis (Study 17). 
The time between finishing treatment and completion of baseline measures also varied 
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across the eight studies which reported this time, although overall the reporting of this 
was generally unclear. Two studies simply reported baseline measures were 
administered after ‘primary curative treatment’ had finished (Studies 10 & 20). Other 
studies were more explicit and reported that baseline measures were administered 
between 3 weeks of treatment cessation (Study 13) and 42 months (Studies 11 & 12). 
Despite not being explicitly reported within the paper, it is likely that patients in Studies 
17-19 had completed their treatment at the point baseline measures had been 
administered given the length of time since a diagnosis had been received (3.6 - 9 
years). Three studies failed to report the time between administration of baseline 
measures and either diagnosis or treatment cessation (Studies 14-16).   
 
 
Completion of follow up measures 
In terms of follow up, all but one study (8) followed patients up more than once. Ten of 
the remaining twelve studies followed patients up twice, one followed patients up 3 
times (13) and another five times (18).  Most studies followed patients up less than 4 
months after baseline measures had been administered (8, 12, 15-20). Only two studies 
followed patients up for 12 months after baseline (10 & 13). This was the maximum 
follow up duration of any study. 
 
 
3.3.1.2. Patient characteristics 
Sample sizes and attrition 
All studies reported both baseline and follow up sample sizes. Table 19 summarises 
sample sizes for each study at both baseline and final follow up time points. There were 
1345 participants in total across all thirteen studies and 1024 participants remaining in 
the total sample at final follow up. Although it should be noted that for two of these 
studies (11 & 12) only two of the original three participant groups were included in 
administration of final follow up measures. This represents an overall attrition of 23.9% 
with attrition levels for each study ranging from 4.8% (Study 19) to 37.5% (Study 20).  
It has been argued that loss to follow-up greater than 20% could be a potential source of 
bias in RCTs (Schulz & Grimes, 2002). Three of the eight RCTs in this review had 
attrition levels higher than 20% (9, 15 & 16). Two of the five non-RCT studies 
reviewed also had attrition levels greater than 20% (10 & 20). 
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Table 19: Review 2 – Sample sizes and attrition 
 
Study 
Total n at 
baseline 
Total n at final 
follow-up 
Overall attrition 
(%) 
8 257 214 16.7% 
9 246 177 28% 
10 74 57 23% 
11 55 20
*
 NK 
12 45 27
*
 NK 
13 154 124 19.5% 
14 87 77 11.5% 
15 176 136 22.7% 
16 161 109 32.3% 
17 41  39 4.9% 
18 20 19 5% 
19 21 20 4.8% 
20 8 5 37.5% 
* These values included only participants from two of the original three groups sampled at 
baseline as the third group was not followed to the final time point; NK = Not known 
 
 
 
Demographics 
The mean age of patients across the entire dataset was 58.6 years old although mean 
ages for each study varied hugely from 48 to 73 years old. Most sampled patients were 
female (n=863; 64%). Seven of the thirteen studies reviewed included only female 
patients (9, 10, 13, 17-20), one included only male patients (8) and the remaining five 
studies sampled both men and women (11, 12, 14-16).  
 
Less than half of studies reported the ethnicity of patients in their sample. From the 
studies that did, between 41% (Study 8) and 100% (Study 19) of recruited patients were 
white Caucasian.  
 
In general, studies used proxy measures to determine the social status of participants 
such as education (9-13, 17-19), occupation (14) or level of income (13, 15-19). Of the 
eight studies measuring patient’s education level, five measured the number of years’ 
patients had spent in education, reporting patients had spent on average 15 years in 
education. Studies 9 and 10 used categorical measures of educational level. Study 9 
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found most recruited patients (53%) had attended ‘higher education’ (college and 
university) while Study 10 reported that only 14% of patients in their sample had 
achieved a similar level, the majority achieving only basic and intermediary education 
levels. Study 13 reported that most patients in their sample (52%) had not received a 
‘tertiary’ level of education but provided no definition of this classification. Six studies 
measured income levels. It was not possible to directly compare these values between 
studies due to the use of incomparable categorical measures which would render any 
conclusions meaningless. Only Studies 8 and 20 provided no measure of patient’s social 
status or any proxy measures to ascertain this.  
 
 
 
3.3.2. Quality assessment 
3.3.2.1. Overall quality 
It is important to distinguish between failure to report a criterion and failure to meet a 
criterion (CRD, 2009), and so each of the thirteen studies were evaluated according to 
the same quality criteria as in Review 1 with the addition of three study quality and two 
reporting quality items relevant to intervention studies (see page 34 for full description 
of the item development and rating system). Scores for both study quality and reporting 
quality based on evident criteria only (those scoring a ‘yes’) were summed and divided 
by the total number of applicable items to obtain a total quality percentage score for 
each study (presented in Table 20 in descending order of total quality). 
 
Study quality scores ranged from 33% (Study 20) to 81% (Study 14), with a median 
score of 65%. Reporting quality scores ranged from 40% (Study 20) to 100% (Study 8) 
with a median score of 69%. Total quality scores ranged from 37% (Study 20) to 82% 
(Study 8) with a median of 72% across all thirteen studies. Although Studies 11 and 17-
20 had the lowest study and reporting quality ratings overall, this is likely to be because 
they were feasibility pilot studies and as such methodologies and findings were 
described in only minimal details. Many of the details required to score more highly for 
study and reporting quality (e.g. recruitment and data collection details, reporting 
internal consistency etc.) were either absent or else only partially reported. 
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Table 20: Review 2 – Study quality, reporting quality and total quality scores 
 
Study 
Study quality 
score (%) 
Reporting 
quality score (%) 
Total quality 
score (%) 
8 65% 100% 82% 
10 80% 80% 80% 
12 71% 81% 76% 
13 76% 75% 76% 
16 69% 81% 75% 
9 65% 81% 72% 
14 81% 63% 72% 
15 69% 69% 69% 
11 53% 56% 55% 
19 57% 47% 52% 
17 50% 44% 47% 
18 50% 44% 47% 
20 33% 40% 37% 
 
 
 
3.3.2.2. Study quality 
Table 21 summarizes criteria judged as evident (rated with a ‘Yes’) to illustrate overall 
study quality for the dataset. Twenty-nine percent of applicable criteria (5/17) were met 
by all reviewed studies (see Appendix IX for complete breakdown of study quality 
ratings for each study). All studies were based on one or more theoretical frameworks 
including, Leventhal’s common sense model. All studies were judged as using 
appropriate methods to answer research questions and administering valid and reliable 
psychological health measures. Furthermore, all studies were considered to interpret 
findings accurately and make appropriate conclusions consistent with their results. 
Criteria which was not evident in all studies but which needs to be considered as 
potentially introducing bias to the overall findings (and which hasn’t already been 
addressed elsewhere in this chapter) will be outlined below. 
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Table 21: Review 2 – Study quality criteria judged as evident  
 
Criterion* Studies 
Percentage 
of all studies 
(n=13) 
1. Based on theoretical framework 8,9,10,11,12,13,14,15,16,17,18,19,20 100% 
3. Appropriate methods used to answer 
research question 
8,9,10,11,12,13,14,15,16,17,18,19,20 100% 
9. Use of valid and reliable 
psychological health measure 
8,9,10,11,12,13,14,15,16,17,18,19,20 100% 
15. Accurate interpretation of findings 8,9,10,11,12,13,14,15,16,17,18,19,20 100% 
16. Conclusions consistent with results 8,9,10,11,12,13,14,15,16,17,18,19,20 100% 
14. Appropriate quantitative analysis to 
test hypothesis 
8,9,10,11,12,13,14,15,16,17,18,19 92% 
10. Recommended use of psychological 
health measure 
8,9,10,12,13,14,15,16,17,18,19 85% 
5. Adequate sample size for statistical 
analysis 
8,9,10,11,12,13,17,18,19 69% 
7. Equal group numbers 12,13,14,15,16 50%* 
8. Groups well matched at baseline 8,11,12,14,17 50%* 
6. Measures used to reduce bias 8,9,12,14,15,16 46% 
2. Well defined research 
question/hypothesis 
10,12,13,14,15 38% 
4. Appropriate recruitment procedure 8,11,13,14,15 38% 
11. Recommended use of illness 
perception measure 
9,10 33%* 
13. Adequate length of follow up 9,10,13,14 31% 
12. Acceptable internal consistency 10,16 15% 
17. Findings generalizable 16 8% 
* From the studies for which this criterion was applicable 
 
 
Recommended use of measures 
Only six of the thirteen studies administered illness perception measures. Of these, only 
Studies 9 and 10 were judged as using their measure (IPQ-R) in a recommended way. 
Studies 8 and 12 were judged as only partly using the measured as recommended due to 
omission of items and modifications to subscales. Study 11 did not provide enough 
detail to determine whether they had administered the measure appropriately and Study 
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13 was judged as not having administered the measure as recommended by developers 
due to their use of only half of one subscale without providing alpha values for internal 
reliability.  All studies administered valid and reliable measures of psychological health 
in full as recommended. 
 
Well defined research question/hypothesis 
Only 38% of the studies reviewed were deemed to have provided a well-defined 
research question and/or hypothesis. The remaining studies provided general aims and 
broad objectives but did not specific what research question they were testing nor did 
they hypothesis what they were expecting to find. 
 
Matched groups 
Only half of the studies which included a control group were judged to have matched 
participants in terms of demographic information, clinical details, sample size or any 
other variable (items 7 & 8). The remaining studies which employed control groups 
were judged as providing unclear details about whether patients had been matched on 
any variables at baseline (Studies 9, 13, 15, 16 & 18).  
 
 
Measures used to reduce bias 
Less than half the studies were considered as having employed any methodological 
measures to reduce bias. Of the 50% of studies that did not, Study 10 was judged as 
having not used any appropriate measures and Studies 11, 13 and 17-20 were judged as 
having provided some indication they had employed measures such as randomisation of 
participants to experimental and control groups for instance, but insufficient details to 
make a definitive ‘yes’ judgement. Again, this may have been because these studies 
(except for Study 13) were pilot studies and provided less detail than most other studies.  
 
Acceptable internal consistency 
Only two of the thirteen studies reviewed were judged to have acceptable internal 
consistency (Cronbach’s alpha coefficient values >.70). Of the remaining eleven 
studies, two (8 & 13) were judged as having partially fulfilled this criterion since some 
of their measures had values within the acceptable range and others did not. A further 
nine studies did not provide alpha coefficients. 
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Generalisability 
The criterion with the poorest quality rating was generalisability of findings. Only Study 
16 was judged as having findings which were generalizable due to having a large 
sample of both male and female participants sampled from several different hospitals 
with a large degree of demographic and clinical diversity (e.g. equal numbers of men 
and women, different cancer diagnoses, wide range of incomes) and had used multiple 
measures to reduce potential bias and included multiple control groups. The remaining 
twelve studies were judged to be partially generalizable to similar patient groups or 
settings but not necessarily beyond these groups due to small sample sizes (Studies 18-
20), high levels of attrition (Studies 9, 10, 15 & 20) and lack of clinical (Studies 8-10 & 
13) or demographic (Studies 8-10 & 13) diversity.  
 
 
 
 
3.3.2.3. Reporting quality 
Papers were analysed according to the quality of information provided. Table 22 
summarises criteria with ‘Yes’ ratings (criteria which was reported to a good standard) 
for each paper to evaluate the quality of reporting (see Appendix X for complete 
breakdown of reporting quality ratings for each study). No single criterion was present 
in all thirteen studies. The most commonly reported criterion was the provision of clear 
intervention details, evident in all but one study (14) which had provided only partial 
information. Thirteen criteria (81%) were present in at least half of all studies. Criteria 
that were not well reported included provision of clear information about control 
groups, reporting of the internal reliability of measures and the explicit 
acknowledgement of potentially confounding variables: each criterion reported by only 
four studies. 
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Table 22: Review 2 – Reporting quality criteria judged as evident 
 
Criterion* Studies 
Percentage 
of all 
studies 
(n=13) 
5. Clear description of the intervention 8,9,10,11,12,13,15,16,17,18,19,20 92% 
4. Clear description of recruitment 
procedures 
8,9,10,11,12,13,14,16,17,18,19 85% 
8. Clear description of data collection 8,10,11,12,13,14,15,16,17,18,19 85% 
10. Clear description of data analysis 
conducted 
8,9,10,11,12,13,14,15,16,19,20 85% 
11. Provision of attrition data 8,9,10,11,13,14,15,16,19,20 77% 
15. Discussion of clinical relevance of 
findings 
8,9,10,12,13,14,15,17,18,20 77% 
2. Clear description of sample 8,9,10,11,12,13,14,15,16 69% 
3. Clear description of setting 8,9,12,14,15,16,17,18,19 69% 
7. Clear definition of psychological health 
measure 
8,9,10,14,15,16,17,18,19 69% 
12. Strengths and limitations of study 
stated 
8,9,10,11,12,13,15,16,20 69% 
13. Problems with study design reported 8,9,11,12,13,15,16,20 62% 
1. Clearly reported aims and objectives 8,9,10,12,13,14,15 54% 
16. Recommendations for clinical practice 
discussed 
8,10,12,14,16,17,18 54% 
6. Clear description of the control group 8,9,12,13 31%* 
9. Reliability of administered measures 
reported 
8,10,13,16 31% 
14. Potentially confounding factors 
reported 
8,9,12,16 31% 
* From the studies for which this criterion was applicable 
 
 
3.3.2.4. Overall risk of bias 
Evaluating the potential impact caused by study quality issues on potential bias is an 
important consideration in the systematic review process to avoid over or 
underestimation of the significance of findings (CRD, 2009). All studies used only self-
report measures of psychological health commonly known to be subjective, relying on 
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patient’s individual interpretation of items (Robson, 2002). Most studies stated patients 
were ‘sent’ questionnaires to complete at home, thus increasing the risk that 
questionnaire items may have been misunderstood. Five studies administered 
questionnaires at assessment sessions either in the patient’s home or in a hospital clinic 
(Studies 8, 11-14) where support to complete the measures was available. This is likely 
to increase the reliability of findings. The fact that all studies administered valid and 
reliable measures of psychological health without modifications may also offset some of 
the potential for measurement bias.  
 
Regarding sample bias, several studies reported that their participants were not 
necessarily experiencing psychological difficulties at baseline. Three studies excluded 
patients from their study if they had evidence of current ‘psychopathology’ during 
clinical interview (Study 13), current ‘psychiatric symptoms’ (Study 8) or major 
depression (Study 20). Several studies also postulated that the participants who 
remained in their studies until the final follow up may have constituted a more 
physically and psychologically healthy patient group compared to drop outs who 
reported worse physical symptoms (Study 16) or who reported worse psychological 
health (Studies 8, 9, 14 & 17-19). Two further studies reported that intervention 
participants reported experiencing below clinical levels of physical and psychological 
distress at baseline (15 & 16). An under-representation of patients who were physically 
and/or psychologically distressed pre-intervention may have impacted upon the ability 
to detect changes or improvements in psychological health post-intervention.  
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3.3.3. Overall findings 
3.3.3.1. Interventions 
 
 
 
 
 
 
 
 
Types of intervention 
Twelve different interventions were developed by the thirteen studies and are described 
in Table 23. These interventions can be subdivided into two distinct types: ‘indirect 
illness perception interventions’ and ‘direct illness perception interventions’.  
 
Indirect illness perception interventions: studies 8-13 
Six studies developed interventions that were not based on the common-sense model 
(CSM), and hypothesised that some form of group-based intervention, not directly 
targeting illness perceptions, would improve patient’s psychological health via indirect 
changes in their illness perceptions. In terms of content, one intervention delivered a 
Cognitive-Behavioural Stress Management (CBSM) group programme (Study 8) and 
five studies described their interventions as educational/rehabilitation group 
rehabilitation programmes, incorporating a range of techniques such as increasing 
physical exercise (Study 9), relaxation training (Studies 8 & 10-13), ‘cognitive 
restructuring’ (e.g. challenging maladaptive thoughts in an attempt to modify them: 
Studies 8 & 10) and group discussion surrounding the experience of having cancer 
(Studies 8-13).  
 
Direct illness perception interventions (studies 14-20) 
Seven studies described interventions which adopted the CSM as a framework with the 
explicit aim of directly modifying patient’s ‘maladaptive’ illness perceptions to improve 
psychological health. All direct interventions were delivered to individual patients or to 
patients and their spouse/carer (16). Although there was some variation in the exact 
nature of these interventions, a common feature was that patients were actively 
encouraged to discuss their perceptions of having (or having previously had) a cancer 
Review 2 – Research question 3: 
What interventions have been developed to directly or indirectly modify 
illness representations for adults with cancer? 
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diagnosis using the common-sense model as a framework for discussion to identify and 
address inaccurate or maladaptive perceptions about their illness.  
 
Four of the direct illness perception interventions (16-19) were variations and 
extensions of the ‘RIDcancerPain’ intervention described in Study 15 for patients 
experiencing cancer pain (see Table 23 for full description). RIDcancerPain is a 60-
minute single session intervention, led by a specialist oncology nurse, using a five-part 
educational approach to encourage patients to describe their beliefs about reporting 
cancer related pain and the use of analgesics using five illness perception domains as a 
structure for discussion (cause, timeline, consequences, cure/control). This intervention 
aimed to identify patient’s misconceptions, discuss the potential losses and limitations 
of these and provide educational information to fill knowledge gaps and facilitate 
change in illness perceptions. Variations and extensions of this intervention included 
incorporating the patient’s spouse/care-giver into the consultations (Study 16), changing 
the patient group (to older adults) and allowing patients to focus the intervention on 
their ‘most bothersome symptom’ (Study 17), increasing the length of contact between 
patients and their specialist nurse (Study 18) and changing the way the intervention was 
delivered from face to face with some telephone support to telephone contact only 
(Study 19).  
 
The two studies not based around the RIDcancerPain intervention (14 & 20) described 
using an ‘individual psychological therapy approach’ to encourage patients to discuss 
their illness perceptions and incorporated additional therapeutic techniques such as 
relaxation (Study 14), reduction of threat monitoring and values based goal setting 
(Study 20).  
 
 
Intervention delivery 
All thirteen interventions except one were delivered face to face: Study 19 was 
delivered over the telephone. Interventions were delivered by a range of health care 
professionals. Seven interventions were delivered by psychologists, either as the main 
facilitator (Studies 8 & 11-13) or as part of a team which included a specialist nurse 
(Study 16), a psychiatrist (Study 20) or ‘unspecified team’ (Study 9). The remaining six 
interventions were delivered by nurses, either as the main facilitator (Studies 14, 15 & 
17-19) or with a social worker (Study 10). 
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Table 24: Review 2 – Intervention session length, frequency & overall duration 
 
Study 
No. of 
sessions 
Session 
duration 
Frequency 
Total 
duration of 
intervention 
Overall length of 
intervention 
(hrs/mins) 
*13 12 2 hrs Weekly 12 weeks 24 hrs 
*10 9 2 ½ hrs 
Weekly then 
fortnightly 
5 months 22.5 hrs 
*8 10 2 hrs Weekly 10 weeks 20 hrs 
*11 4 2 hrs Weekly 4 weeks 8 hrs 
*12 4 2 hrs Weekly 4 weeks 8 hrs 
*20 5 1 ½ hrs NS NS 7.5 hrs 
14 6 1 hr Weekly 6 weeks 6 hrs 
16 3 
1 x 20-80 mins  
+ 2 x 10 mins 
Fortnightly 4 weeks 2 hrs 40 mins (max) 
18 6 
30-75 mins  
+ 5 x 10 mins 
Fortnightly 
then bi-
monthly 
16 weeks 2 hrs 5 mins (max) 
19 6 
30-75 mins  
+ 5 x 10 mins 
Fortnightly 
then bi-
monthly 
16 weeks 2 hrs 5 mins (max) 
17 2 
30-75 mins  
+ 1 x 10 mins 
Monthly 4 weeks 1 hr 15 mins (max) 
15 1 20-60 mins Once 1 day 1 hr (max) 
9 6 NS Daily 6 days NK* 
NS = Not stated; NK = Not known; *This information cannot be calculated since session duration was not reported in 
the paper; * studies were all effective in improving psychological health and modifying illness perceptions 
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3.3.3.2. Results of individual studies 
Findings from the thirteen studies are summarized in Table 25 (‘indirect illness 
perception interventions’) and Table 26 (‘direct illness perception interventions’), in 
relation to Research question 4. 
 
 
Table 25: Review 2 -  Main findings for ‘indirect illness perception 
interventions’ 
 
Study 8: Traeger et al., (2013). Identifying how and for whom cognitive-behavioral 
stress management improves emotional well-being among recent cancer survivors 
 
Study description: Explored whether a cognitive-behavioural stress management 
(CBSM) intervention would improve emotional wellbeing in men treated for prostate 
cancer via changes to their illness perceptions 
Research question 4 
To what extent are these interventions effective in improving psychological health and 
modifying illness perceptions? 
 
 CBSM patients had significantly higher emotional wellbeing (EWB) 2 weeks after 
the 10-week intervention than control group patients, even after controlling for 
SES (household income & years of education) and pre-test EWB 
 
 Improvements in EWB were not directly explained by changes in the five illness 
perceptions measured (personal and treatment control, coherence, personality and 
behavioural causes) 
 
 Higher levels of perceived stress pre-treatment predicted greater increases in 
perceptions of illness coherence and treatment control over time only for 
intervention participants  
 
 Greater increases in these perceptions combined (not independently) predicted 
greater increases in post-intervention EWB 
 
 The intervention was effective in increasing illness perceptions of treatment 
control and illness coherence which buffered CBSM patients from the negative 
impact of stress on EWB 
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Table 25: Review 2 -  Main findings for ‘indirect illness perception 
interventions’ (continued) 
 
 
Study 9: Lichtenstein Jorgensen et al., (2009). An exploratory study of associations 
between illness perceptions and adjustment and changes after psychosocial 
rehabilitation in survivors of breast cancer 
Study description: Explored patterns of illness perception changes and subsequent 
changes in distress in breast cancer survivors after participation in a rehabilitation 
course 
Research question 4 
To what extent are these interventions effective in improving psychological health and 
modifying illness perceptions? 
 
 The intervention was not effective in improving emotional distress for either the 
intervention or ‘standard care’ control group 
 
 Illness perceptions did not change significantly over time in either intervention 
or control group  
 
 Patients were recruited more than 1 year after surgery and may therefore 
represent an ‘emotionally well-adjusted’ sample who did not need an 
intervention so therefore did not benefit from it 
 Study 10: Fischer et al., (2013). From despair to hope: A longitudinal study of 
illness perceptions and coping in a psycho-educational group intervention for women 
with breast cancer 
Study description: Explored changes in both the illness perceptions and distress of 
women with breast cancer 12 months after a 9-session psychoeducational group 
intervention 
Research question 4 
 
 Participants distress scores decreased significantly immediately after the 5-
month intervention (T2) and remained stable over the next 7 months (T3) 
 
 The number of patients in the sample with ‘clinical levels’ of distress decreased 
from 49% at baseline to 23% and 21% at T2 and T3 respectively 
 
 Change scores between baseline and T2 in illness identity, timeline chronic and 
cyclical predicted an additional 9% of the variance in T2 distress after 
accounting for baseline distress and education level 
 
 Change scores between baseline and T3 in illness identity, consequences and 
cyclical timeline explained an additional 20% variance in T3 distress after 
accounting for baseline distress and education level 
 
 Changes in cyclical timeline beliefs were the strongest predictor of T2 and T3 
distress 
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Table 25: Review 2 -  Main findings for ‘indirect illness perception 
interventions’ (continued) 
 
 
 Study 11: Schuurs & Green (2013). A feasibility study of group cognitive 
rehabilitation for cancer survivors: enhancing cognitive function and quality of life. 
Study description: Evaluated the feasibility of a 4-week cognitive group rehabilitation 
programme on cognitive functioning and psychological outcomes 
Research question 4 
To what extent are these interventions effective in improving psychological health and 
modifying illness perceptions? 
 
 Psychological distress did not improve significantly for patients in either the 
intervention group or either of the control groups between baseline and 4 weeks 
(T2) and 2 months (T3) follow ups. 
 
 Psychological distress only decreased significantly between baseline and T2 for 
intervention patients who were considered ‘clinically distressed’ pre-intervention 
- this improvement was maintained 3 months later 
 
 The only illness perception to change over time was illness coherence (regarding 
cognitive difficulties associated with cancer) which increased significantly for 
intervention participants immediately after the intervention – these benefits were 
maintained 3 months later 
Study 12: King & Green (2015). Psychological intervention for improving cognitive 
function in cancer survivors: a literature review and randomized controlled trial 
Study description: Evaluated the efficacy of a 4-week cognitive group rehabilitation 
programme on cognitive functioning and psychological outcomes  
Research question 4 
 
 Psychological distress and emotional functioning improved significantly for 
intervention participants between baseline and 2-weeks after the end of the 
intervention (T2) – these improvements were maintained 3-months later (T3)  
 
 Illness perceptions improved significantly between baseline and both T2 and T3 
for intervention participants only 
 
 Cognitive self-efficacy (confidence in managing symptoms improved 
significantly between T1 and T3 for intervention participants only 
 
 There was no correlation between changes in illness perceptions over time and 
any other variable, including cognitive self-efficacy 
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Table 25: Review 2 - Main findings for ‘indirect illness perception interventions’ 
(continued) 
 
 
 
Study 13: Cameron et al., (2007). Changes in emotion regulation and psychological 
adjustment following use of a group psychosocial support program for women recently 
diagnosed with breast cancer 
Study description: Examined the efficacy of a 12-week psychosocial group program 
on a range of outcomes including appraisal of personal control, emotional wellbeing 
and anxiety 
Research question 4 
To what extent are these interventions effective in improving psychological health and 
modifying illness perceptions? 
 
 Intervention participants reported greater improvements in emotional wellbeing 
(EWB) between baseline (T1) and the end of the intervention 12 weeks later 
(T2) compared to ‘standard care’ and ‘intervention decliner’ control groups 
(which also improved significantly but not to the same degree). However, all 
groups improved significantly between baseline and 6- (T3) and 12- (T4) month 
follow-ups 
 
 Intervention participants reported significantly decreased levels of anxiety 
between baseline and T2, whereas control group participants did not. However, 
all groups decreased significantly in anxiety levels between baseline and T3 and 
T4 follow ups 
 
 At T2, intervention participants reported higher perceptions of personal control 
(the only illness perception measured) than participants in either control group 
 
 At T3, there was no differences between intervention and control group 
participants on perceived control 
 
 At T4, intervention participants had significantly higher perceptions of personal 
control than ‘decliners’ 
 
 There was no significant difference between T1 and T4 perceptions of personal 
control for intervention participants  
 
 Personal control scores continuously decreased between T1 and T2, T2 and T3 
and T3 and T4 for both control groups, these decreases were statistically 
significant in the ‘decliner’ group 
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Table 26: Review 2 -  Main findings for ‘direct illness perception interventions’ 
 
 
Study 14: Humphris & Rogers (2012). AFTER and beyond: cancer recurrence fears 
and a test of an intervention in oropharyngeal patients 
Study description: Examined the efficacy of a 6-week manualised representational 
intervention on fear of cancer recurrence and psychological distress in patients with 
oral and oropharyngeal cancer patients 
Research question 4 
To what extent are these interventions effective in improving psychological health and 
modifying illness perceptions? 
 
 There were no significant decreases in either anxiety or depression for 
intervention participants at 4 or 8 month follow ups.  
 
 Control group participants increased in anxiety between baseline and 8 month 
follow up 
 
 Intervention participants level of ‘anxious preoccupation’ and ‘fear of 
recurrence’ decreased significantly between baseline and 4 month follow up but 
improvements were not sustained at 8 month follow up 
 
 Poor session attendance levels (2 session median attendance) 
 
 Participants were significantly below the clinical threshold for anxiety and 
depression at baseline 
 
Study 15: Ward, et al., (2008). A randomized trial of a representational intervention to 
decrease cancer pain 
Study description: Measured the effects of a one-session representational intervention 
on pain management and quality of life 
Research question 4 
 
 There was no significant change in psychological functioning for intervention or 
control group participants at 1- (T2) or 2- (T3) month follow ups 
 
 Intervention participant’s perceptions of ‘usual pain severity’ improved and 
perceived barriers to using analgesic medication decreased significantly after the 
intervention 
 
 High number of sample reported their pain was 1/10 on a 0-10 scale of severity. 
Patients who dropped out were more unwell so remaining sample were not 
necessarily in need of an intervention 
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Table 26: Review 2 -  Main findings for ‘direct illness perception interventions’ 
(continued) 
 
Study 16: Ward, et al., (2009). A randomized trial of a representational intervention 
for cancer pain: Does targeting the dyad make a difference? 
Study description: Examined the comparative efficacy of a representational 
intervention with individual patients (‘solo’) and with a significant other (dyad) to 
improve cancer pain, quality of life and mood 
Research question 4 
To what extent are these interventions effective in improving psychological health 
and modifying illness perceptions? 
 
 Participants in either intervention group (‘solo’ or ‘dyad’) did not significantly 
improve in negative mood between baseline and 5- (T2) or 9- (T3) week follow 
up  
 
 Intervention participants in both groups (solo and dyad) showed greater 
decreases in attitudinal barriers such as reporting pain to health care 
professionals and use of analgesics between baseline and T3 follow up 
compared to participants in standard care control group  
 
 Attitudinal barrier change scores between baseline and T3 mediated the effects 
of both solo and dyad interventions on negative mood 
 
Study 17: Heidrich, et al., (2009). An individualized representational intervention to 
improve symptom management in older breast cancer survivors: Three pilot studies 
(Pilot study 1) 
Study description: Evaluated the feasibility and acceptability of a 2-session 
representational intervention (IRIS) for older breast cancer survivors and the effects 
upon symptom distress and management, depression and anxiety 
Research question 4 
 
 The intervention was not effective in reducing anxiety or improving mood. Ten 
weeks after the intervention scores for intervention participants did not differ 
significantly from ‘usual care’ control participants 
 
 The intervention was effective at reducing symptom distress but not overall 
quality of life (including psychological functioning) which may reflect stability 
of quality of life in older adults with other comorbidities 
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Table 26: Review 2 -  Main findings for ‘direct illness perception interventions’ 
(continued) 
 
Study 18: Heidrich et al., (2009). An individualized representational intervention to 
improve symptom management in older breast cancer survivors: Three pilot studies – 
(Pilot study 2) 
Study description: Evaluated the feasibility and acceptability of an extended 6 
session IRIS for older breast cancer survivors and the effects upon symptom distress 
and management, depression, anxiety and mental health 
Research question 4 
To what extent are these interventions effective in improving psychological health 
and modifying illness perceptions? 
 
 Intervention participants did not improve in either depression, mental health or 
level of anxiety 16 weeks after the intervention and did not differ from waitlist 
control participants 
 
 The intervention was effective at reducing negative mood from symptoms but 
not overall quality of life (including anxiety and depression) which may reflect 
stability of broader quality of life in older adults 
 
 Multiple comorbidities and life events may delay implementation of changes in 
this patient population 
Study 19: Heidrich et al., (2009). An individualized representational intervention to 
improve symptom management in older breast cancer survivors: Three pilot studies 
(pilot study 3) 
 
Study description: Evaluated the feasibility and acceptability of a 6 session IRIS 
delivered over the telephone for older breast cancer survivors and the effects upon 
symptom distress and management, depression, anxiety and negative mood  
Research question 4 
 
 Intervention participants did not improve in mental health or level of anxiety at 
either 8- (T2) or 16- (T3) weeks follow up  
 
 Intervention participants decreased significantly in their ‘negative mood 
attributed to symptoms’ (e.g. anger, confusion, tension and depression) from 
baseline to both 8 (T2) and 16 (T3) week follow up 
 
 Barriers to symptom management (e.g. communication difficulties with health 
care professionals) may have mediated the influence of the intervention on 
distress 
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Table 26: Review 2 -  Main findings for ‘direct illness perception interventions’ 
(continued) 
 
Study 20: Smith, et al., (2015). Pilot of a theoretically grounded psychologist-
delivered intervention for fear of cancer recurrence (Conquer Fear) 
 
Study description: Evaluated the feasibility, acceptability and efficacy of a 
psychologist-delivered 5-session intervention to reduce fear of cancer recurrence and 
cancer-specific anxiety  
Research question 4 
To what extent are these interventions effective in improving psychological health 
and modifying illness perceptions? 
 
 Cancer specific anxiety improved significantly immediately post intervention 
and increased further 2 months later 
 
 Fear of cancer recurrence decreased significantly between baseline and follow 
up time points 
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3.3.3.3. Data synthesis 
 
 
 
Findings from each study were collated and summarised according to intervention 
details and relative efficacy in improving psychological health and modifying illness 
perceptions. Findings are summarised in Tables 27 and 28 and described below. 
 
 
Indirect illness perception interventions 
Studies 8-13 measured whether a variety of interventions were effective in improving 
psychological health and changing illness perceptions. 
 
Changes in illness perceptions 
Illness representations changed significantly for all but one indirect intervention study 
(9). One study reported illness representations (measured by the B-IPQ as a whole scale 
only) improved significantly between pre- and post-intervention time points (12) but did 
not expand on changes in any individual illness perceptions. The remaining four studies 
reported improvements over time for intervention participant’s levels of illness 
coherence (8 & 11), perceptions of treatment control (8), personal control (13), 
consequences, illness identity, chronicity and the cyclical nature of their illness (10). 
Although it should be noted that for Study 13, greater increases in participant’s 
perceptions of personal control compared to control participants were only evident 
immediately after the intervention: this difference was not maintained at 6-  and 12-
month follow ups. 
 
Improvements in psychological health 
In terms of psychological health, four studies found that their interventions were 
effective in improving emotional wellbeing (8 & 13) and decreasing psychological 
distress (10 & 12). One study found their intervention was somewhat effective in 
reducing psychological distress but only for participants in the intervention group whose 
distress scores were in the clinical range at baseline (11). Only one indirect intervention 
study found their intervention was not effective in reducing emotional distress (9).   
Review 2 - Research question 4:  
To what extent are these interventions effective in improving psychological 
health and modifying illness representations? 
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Direct illness perception interventions 
Studies 14-20 measured whether interventions specifically designed to directly modify 
patient’s illness perceptions would improve some aspect of their psychological health. 
 
Improvements in psychological health 
Only one study reported improvements for intervention participants in psychological 
health (20). The remaining six direct intervention studies reported no benefits for 
participants in terms of their overall psychological health. 
 
Changes in illness perceptions 
None of the direct interventions measured illness perceptions. 
 
Changes in other variables 
Several other variables were reported to have improved and, while not representing 
overall psychological health, are worthy of note. For example, several studies reported 
that their interventions were effective in reducing participants fear of cancer recurrence 
(14 & 20), their level of anxious preoccupation (8), negative mood or distress from 
symptoms
7
 (17, 18 & 19) and attitudinal barriers to symptom management such as 
difficulties communicating pain to health care professionals and appropriate use of 
analgesics (16 & 19). 
 
3.3.4. Review 2: Summary 
There was much methodological variability in the thirteen papers reviewed, making 
synthesis and between-study comparisons challenging and which may have increased 
the possibility for bias. From the thirteen studies reviewed, seven designed illness 
perception interventions based on Leventhal’s common sense model to directly modify 
illness perceptions. Only one of these studies reported their intervention had been 
effective in improving the psychological health of participants. The remaining six 
studies employed indirect interventions to improve psychological health, five of which 
found beneficial effects of the intervention on psychological health of participants and 
all reported improvements in one or more illness perceptions over time.   
  
                                                 
7
 This was described as a variable distinct from general mood 
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4 
DISCUSSION 
 
 
4.1. Overview 
Two systematic reviews were conducted to explore the prospective relationship between 
illness representations and the psychological health of adults with a cancer diagnosis 
and to evaluate interventions which have attempted to modify illness perceptions to 
improve psychological health. This chapter will firstly summarize and interpret overall 
findings for each review relating to each of the four research questions. Important 
strengths and limitations of reviewed studies and of the review methodology process 
will then be considered in terms of their potential impact upon overall conclusions. 
Finally, clinical implications of these findings will then be discussed. 
 
 
4.2. Review 1: Principal findings  
This review evaluated studies which measured the prospective relationship between 
illness representations and future psychological health. Seven studies were identified 
which measured this relationship in patients with a range of cancer diagnoses including 
breast cancer, prostate cancer, colorectal cancer, head and neck cancer and oesophageal 
cancer. 
 
 
 
All but one of the seven studies reviewed reported that illness representations (i.e. the 
collective term for illness perceptions) were predictive of future psychological health in 
cancer patients. Overall, patients with the most negative illness representations had the 
worst psychological health over time. This finding is in line with two similar published 
Research question 1: Are illness representations prospectively associated with 
future psychological health in adults with cancer? 
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systematic reviews for patients with a range of chronic illnesses (Hagger & Orbell, 
2003) and for those with a cancer diagnosis (Richardson et al., 2016).  
 
Three main approaches to exploring this prospective relationship were undertaken to 
determine the strength of this association. Two approaches involved clustering patients 
into groups with similar illness perceptions either at one point in time (Study 6) or over 
time as a function of change (Study 1). Both studies found that patient clusters (patients 
with similar illness perceptions) were significantly predictive of future depression and 
anxiety. Using a clustering approach was useful in determining which patient clusters 
were particularly ‘at risk’ of developing psychological difficulties in the future. Four of 
the remaining five studies not using a clustering approach found baseline illness 
representations were predictive of future psychological health.  
 
 
 
 
All nine illness perceptions suggested by the CSM (i.e. identity, cause, consequence, 
timeline-acute/chronic, timeline-cyclical, illness coherence, emotional representation, 
personal control, treatment control), were found to be significantly predictive of future 
psychological health by at least one study, either as part of an illness perception cluster 
or independently of other illness perceptions. Perceptions about illness identity and the 
consequences of having cancer were found to be predictive of psychological health in 
four of the seven studies (57%) that measured them. Comparatively, emotional 
representations were least often found to be predictive of psychological health (33%) 
but were also least often measured.  
 
Only Study 2 did not find a significant association between any illness perception and 
psychological health, despite measuring all nine possible illness perception domains 
using the IPQ-R. However, this study did find small but significant relationships 
between illness perceptions and global quality of life, which included nine subscales of 
functioning. It is possible therefore, that the lack of a significant association may be a 
methodological artefact of using only a 4-item ‘emotional functioning’ subscale to 
Research question 2: Which illness perceptions best predict psychological 
health? 
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represent psychological health. This subscale may not have been comprehensive or 
sensitive enough to detect a relationship.  
 
The two studies which conducted cluster analysis to group patients together according 
to similarities in illness perceptions revealed that some patients were more likely to 
experience poor psychological health over time than others. In Study 1 (Dempster et al., 
2010), four distinct patient clusters were identified in a large sample of oesophageal 
cancer survivors. Only one of these groups of patients (Cluster 1) reported increasingly 
positive illness perceptions over the 12-month study. Illness perceptions became 
increasingly negative over time to varying degrees in the remaining three patient 
clusters. Patients in Cluster 3 reported a significantly greater deterioration in most 
measured illness perceptions over time compared to patients in Clusters 2 and 4 which 
had decreases in some but not all. Dempster et al., suggest that increased perceptions 
that their cancer could not be controlled either by themselves or by treatment 
differentiated Cluster 3 patients from those in other clusters. They suggest that this 
sense of hopelessness/helplessness is characteristic of patients in this cluster and could 
be key to understanding the comparatively greater increases in both depression and 
anxiety over time.  
  
Using a different clustering approach on baseline illness perception scores only, Study 6 
(McCorry et al., 2012) found two illness perceptions clusters in a sample of newly 
diagnosed breast cancer patients.  Women in Cluster 1 had a poorer sense of illness 
coherence, were more likely to believe their illness was chronic and cyclical and had 
more severe consequences, attributed more symptoms and causation to their illness and 
had stronger beliefs that it could not be controlled at baseline. These patients were 
significantly more likely to experience depression and anxiety 6 months later than 
women Cluster 2 who had significantly more positive baseline illness perceptions.  
 
Findings from Studies 1 and 6 share similarities with patients in a study of chronic pain 
patients (Hobro, Weinman, & Hankins, 2004). Cluster analysis of patient’s illness 
perceptions in Hobro et al’s. study revealed two distinct groups of patients; ‘adaptors’ 
and ‘non-adaptors’. Patients identified as non-adaptors reported poorer understanding of 
their pain, a higher number of attributable symptoms, higher perceived consequences 
and more negative beliefs in the efficacy of pain treatment than adaptors and were more 
likely to experience depression than adaptors. As with Cluster 3 patients in Study 1 in 
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this review, a key characteristic of non-adaptors was their comparatively poor 
perceptions of personal control. Hobro et al., suggest that this negative pattern of 
thinking for non-adaptors may represent a cognitive process known as ‘catastrophizing’ 
common in individuals with psychological difficulties such as depression which may 
represent a tangible and modifiable target for psychological intervention. 
 
 
4.3. Review 2: Principal findings  
This review aimed to identify what interventions have been developed to modify illness 
representations in cancer patients. Thirteen studies described twelve different 
interventions to modify illness representations and improve several psychological 
outcomes in cancer patients. Interventions were evaluated for their effectiveness in 
improving psychological health and modifying illness perceptions.  
 
 
 
 
 
Seven studies described ‘direct’ illness perception interventions (14-20). These studies 
adopted the common-sense model (Leventhal & Diefenbach, 1992) as a theoretical basis 
for the intervention’s development, to directly modify ‘maladaptive’ illness 
representations.  All direct interventions were delivered to individual patients. Although 
there was some variation in the exact nature of these interventions, their common 
feature was that patients were actively and explicitly encouraged to discuss their 
perceptions of having (or having previously had) a cancer diagnosis along multiple 
illness perception domains in order that facilitators could identify and address 
inaccurate or maladaptive beliefs about their illness.  
 
The remaining six studies (8-13) developed ‘indirect’ illness perception interventions 
that did not aim to directly influence patient’s illness perceptions. Instead, these studies 
evaluated whether a range of interventions would lead to improvements in 
psychological health and whether these improvements could be explained by changes in 
Research question 3: What interventions have been developed to modify 
illness representations for adults with cancer? 
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illness perceptions, hypothesising interventions would modify illness perceptions 
indirectly.  All indirect interventions were delivered as group programmes. One study 
used a manualised Cognitive-Behavioural Stress Management approach (CBSM: Study 
8) and the remaining five studies employed a broad range of rehabilitation techniques 
such as goal setting, increasing exercise levels, increasing social networks and 
opportunities, education and general group discussion. Several studies also incorporated 
therapeutic techniques such as breathing exercises (Study 10) relaxation (Studies 8 & 
11-13), imagery and mediation (Study 13). 
 
 
 
 
 
Indirect illness perception interventions 
Five of the six indirect intervention studies reported they were effective in improving 
the psychological health of patients with cancer (8 & 10-13). Although the cognitive 
rehabilitation intervention described in Study 11 was only effective for patients who 
were within the clinical range of significant distress upon entering the intervention.  
 
Indirect interventions that were effective in improving psychological health were also 
effective in modifying a range of different illness perceptions. Levels of illness 
coherence were significantly higher post-intervention for patients in two studies (8 & 
11), although given all six of these interventions delivered group programmes that 
incorporated teaching elements (e.g. increasing knowledge of cancer, side effects of 
medication & expected difficulties etc.), it is perhaps surprising that more studies did 
not report improvements in patient’s coherent understanding of their condition. 
Perceptions of personal and treatment control were also significantly improved by two 
interventions (Studies 8 & 13). However, post-intervention increases in perceptions of 
personal control were short-lived for patients in Study 13 whose perceptions, after 12 
months, had returned to baseline levels despite maintaining improvements in their levels 
of anxiety. The intervention described in Study 10 yielded the greatest degree of 
changes to patient’s illness perceptions over time, reporting decreases in illness identity, 
Research question 4: To what extent are these interventions effective in 
improving psychological health and modifying illness representations? 
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perceived consequences, chronicity and cyclical timeline in a sample of women with 
breast cancer after 12 months. 
 
Direct illness perception interventions 
Only one of the seven direct illness perception interventions reported significant 
improvements in patient’s psychological health (Study 20). This manualised 
intervention aimed to reduce the impact of fears of cancer recurrence and patient 
anxiety by addressing illness perceptions in ‘individual therapy sessions’. Unlike the 
other six direct interventions that were not effective in improving psychological health, 
this intervention incorporated relaxation training, “cognitive restructuring” and 
homework based activities to facilitate in-session discussions and support the 
consolidation of learning. In this regard, it was more like the content delivered by the 
generally more effective indirect illness perceptions interventions. 
 
 
 
4.4. Clinical implications 
4.4.1. Review 1: Illness representations as useful and modifiable targets for intervention 
Overall, illness representations were prospectively predictive of psychological health in 
adults with a range of cancer diagnoses. Patients with the most negative illness 
perceptions (or the most significant decline in illness perceptions over time) were those 
who were more likely to experience psychological difficulties such as anxiety, 
depression, distress and poor psychological wellbeing at some point in the future. Two 
studies were also able to identify cancer patients who might be considered ‘at risk’ of 
developing significant anxiety difficulties in the future based on their illness perceptions 
at the point of diagnosis or the changes in their illness perceptions over time. As such, it 
is evident that illness representations do represent an important modifiable target for 
intervention in this patient group. 
 
 
4.4.2. Review 2: Using the CSM as a model for developing interventions 
The appropriateness of using the CSM to predict psychological health outcomes 
The CSM theorises that when individuals become unwell, they will rely upon their 
cognitive and emotional representations of illness to make sense of their condition and 
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select an appropriate coping strategy. The model further hypothesises that coping 
responses are continuously monitored and evaluated by the individual and/or changed in 
terms of their relative success or failure. Illness perceptions may also need to be revised 
by the individual depending on the success of a coping response. In their meta-analysis 
of research exploring links between illness perceptions and coping in physical illness, 
Dempster, Howell and McCorry (2015) describe the evolving use of the CSM in health 
care research.  Research has often used behavioural measures to represent patient’s 
coping responses to illness (e.g. self-care, medication adherence, routine clinic 
attendance). However, the CSM has more recently been used to explain both physical 
and psychological outcomes such as quality of life, physical functioning, anxiety and 
depression. Dempster et al., argue that while there is lots research linking elements of 
the CSM to psychological outcomes in physical illness, using the CSM in this way is an 
‘extrapolation of the original model’ (pp.506) which does not explicitly acknowledge 
the role of illness representations in psychological outcomes such as distress, anxiety or 
mood for example. Dempster et al., argue that this may have led to a lack of consistency 
in the application of the CSM in research focussing on individuals with physical illness 
and the subjective interpretation of the definition of psychological outcomes (potentially 
as a proxy for coping responses) and the ability of the CSM to explain these.   
 
Interestingly, findings from two studies in Review 2 (17 & 18) revealed that although 
direct illness perception interventions were largely ineffective in improving 
psychological health outcomes, they were effective in modifying health behaviours such 
as re-engaging with health care providers, initiating a new treatment regime and 
changes to self-care strategies to more effectively manage pain symptoms. Ward et al., 
(2009: Study 16) suggest that using a ‘Representational Approach’ (an intervention 
based around the CSM) can be effective in guiding the content and process of an 
intervention and can facilitate changes in beliefs, for these changes to be translated into 
improved outcomes, additional steps are also needed. Some of these steps might be 
better conceptualised by using additional health models such as the transtheoretical 
model of behaviour change (Prochaska, DiClemente, & Norcross, 1992): an integrative 
biopsychosocial model which acknowledges explain individual’s readiness to make 
behavioural changes to improve their physical and psychological health. Research has 
shown this to be an effective model for assessing which patients are likely to make use 
of and benefit from intervention (Brogan, Prochaska, & Prochaska, 1999). The Theory 
of Planned Behaviour (Ajzen, 1985) may also prove useful in understanding the relative 
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importance of the health beliefs of significant others and an individual’s behavioural 
intention which is likely to predict whether they will make changes.   
 
Poor conceptualisation and measurement of the CSM model in interventions 
Findings from Review 2 would suggest that on the whole using a direct approach to 
changing illness perceptions to improve psychological health is not effective. However, 
of the seven studies which had explicitly used the CSM as a framework for developing 
their intervention (direct interventions), none measured illness perceptions using a 
quantifiable measure, despite describing themselves as ‘representational approaches’. 
Without measuring illness perceptions, it would be difficult to surmise how well 
represented the CSM was in these types of intervention. The poor operationalisation and 
measurement of illness perceptions in direct interventions makes it difficult to draw 
conclusions about using the CSM to directly inform interventions. However, it would be 
unwise to conclude on the basis of such studies whether ‘representational approaches’ 
are ineffective: we simply don’t know enough about why they didn’t work. If an 
intervention doesn’t measure the key component it is aiming to modify then it is 
impossible to conclude why it is or isn’t effective. The fact remains that we don’t really 
know how well these interventions tapped into illness perceptions at all because they 
didn’t measure illness perceptions. It is possible that they may have accessed illness 
perceptions (e.g. identified what they were) but been unable to convert them into 
meaningful improvements in psychological health because of missing elements 
necessary for ‘successful’ interventions. It is important for the development of illness 
representational interventions to consider how to translate changes in illness perceptions 
into successful outcomes: talking about illness perceptions alone is clearly insufficient.  
 
 
4.4.3. Important considerations in effective interventions 
Findings revealed that indirect illness perception interventions (those which aimed to 
modify illness perceptions indirectly – not using the CSM as a framework) were 
generally effective in improving psychological health and changing illness perceptions 
but that interventions designed to direct modify illness perceptions were largely 
ineffective in improving psychological health. However, there are a number of factors 
which require further consideration before making generalised conclusions about the 
efficacy of these interventions. 
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4.4.3.1. Group vs. individual approaches 
There was a general superiority of group interventions over individual approaches in 
improving psychological health in Review 2. Ascher-Svanum and Whitesel (1999) 
suggest that several important factors are likely to play a role in the efficacy of group 
approaches to improve psychological distress such as level of interpersonal support 
from peers, opportunities to share concerns and receive group validation, the presence 
of positive peer role models, being part of a cohesive group and on a basic level, 
understanding their difficulties are not theirs alone. The benefits of peer support groups 
and psychosocial/psychoeducational groups within cancer populations are well cited 
within health care literature and there are multiple published reviews on their efficacy 
(Gottlieb & Wachala, 2007; Hoey, Leropoli, White, & Jefford, 2008).  
 
 
4.4.3.2. Complex vs. simple interventions: Active components 
Complex interventions have been described as those containing several components 
which may interact with one another to improve efficacy of an intervention (Craig , et 
al., 2008). In this regard, effective interventions reviewed here were significantly more 
complex than ineffective interventions, and comprised multiple components. With only 
one exception (Study 20), effective interventions were delivered as part of a group 
programme and so also had the added benefit of increasing social support.  By 
comparison, ineffective interventions reviewed here were significantly less complex, 
comprising only a teaching component which consisted of one or more structured 
conversations between individual patients and ‘interveners’ who attempted simply to 
challenge misconceptions and replace them with ‘correct’ information.  
 
Research has suggested that more complex interventions may be effective because they 
are more likely to contain ‘active ingredients’ helpful in facilitating change (Craig , et 
al., 2008), particularly in relation to improving psychological health and subsequent 
health behaviour changes (Collins & Dozois, 2008; Moos, 2007). Indeed, effective 
interventions reviewed here reported many active ingredients which may have 
facilitated improvements in psychological health including increased access to social 
support, provision of information, homework based activity, group discussion to 
reinforce skills, focus on increasing self-efficacy by encouraging problem-solving, 
training in goal setting, improving interpersonal skills, encouraging open discussion of 
shared experiences, increasing physical exercise, increasing relaxation, behavioural 
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experimentation and written emotional disclosure to improve expression of emotions. 
The potential disadvantage of such complex interventions is that often, and this was the 
case for this review, insufficient information is available to allow replication of the 
intervention or to determine which ingredients or indeed combination of ingredients are 
absolutely necessary for the intervention to be effective (Michie & Abraham, 2004). In 
other words the more complex the intervention, the more difficult it becomes to identify 
the mechanisms of change.  
 
Interestingly, relaxation training was part of all effective interventions in Review 2. 
Conversely, relaxation training was notably absent from six of the seven non-effective 
interventions. In a recent large scale meta-analysis of 198 studies of both individual and 
group psychotherapy and group psychoeducational (provision of education and 
information to help individuals better understand and cope with a condition) approaches 
to improve the psychological health of cancer patients, Faller et al., (2013) found that 
while small to medium effect sizes were observed, relaxation training was key to many 
intervention’s success. As such this is potentially a key active component of such 
interventions and may be a useful guide to developing future interventions in this 
patient group.  
 
4.4.3.3. Intervention intensity 
Effective interventions were all conducted weekly over a number of weeks or months 
with a minimum session duration of 90 minutes and a minimum overall 
patient/facilitator contact of 7 ½ hours.  The only direct intervention to effect change 
had the longest therapeutic contact between patients and therapists/facilitators of any 
study (Study 20). This supports a recent review and meta-analysis of psychosocial 
intervention studies for cancer patients (Faller, et al., 2013) which found a moderation 
effect of intervention duration in that longer interventions produce more sustained 
effects on psychological distress. Ineffective interventions in Review 2 were those of 
the shortest duration with less overall patient-therapist contact (Studies 14-19). The 
indirect intervention described in Study 9 was conducted over 6 consecutive days rather 
than several weekly sessions and may not have provided sufficient time for patients to 
consolidate learned material before the end of the intervention to translate this 
information into perceptual and/or psychological changes. This intervention may simply 
have been too intense for patients. There may be an optimum way of delivering these 
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interventions regardless of content. As a benchmark for effectiveness, patients in Study 
10 reported the most significant improvements in psychological health and illness 
representations. This intervention delivered 2 ½ hour sessions weekly for several weeks 
then fortnightly to allow patients to consolidate learning. All ineffective interventions 
involved either the least patient contact or the most but delivered too close together to 
be useful. 
 
 
4.4.3.4. Intervention recipients and baseline levels of psychological health 
Faller et al. found intervention studies that preselected participants based on their level 
of distress (i.e. selected those who were within clinical ranges of psychological 
distress), tended to be more effective. Multiple studies in Review 2 reported that 
patients were not ‘clinically’ distressed before entering the intervention (Studies 9, 10, 
14, 17-19), most of which were ineffective in improving psychological health or 
changing illness perceptions. Furthermore, greater and potentially problematic attrition 
rates (Schulz & Grimes, 2002) reported by several studies could suggest that those who 
dropped out were more physically or psychologically unwell. It has been suggested that 
in studies with high rates of attrition, ‘completers’ may be less in need of an 
intervention to improve their psychological health than those who drop out of the study 
- something which may in fact impact true effect sizes (Hui, Glitza, Chisholm, Yennu, 
& Bruera, 2013).  
 
4.4.4. Recommendations 
 
 Future interventions need to measure illness representations using a valid and 
reliable measure such as the IPQ-R to determine the mechanisms of change, 
particularly if their intervention aims to modify illness perceptions. Most 
interventions which aimed to directly modify illness representations weren’t 
effective in improving psychological health but may have made changes to illness 
perceptions. This information would be extremely useful in terms of developing 
future useful interventions.  
 
 Research has noted there are potential difficulties in developing group programmes 
such as those described by the intervention studies identified in Review 2 to 
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improve psychological outcomes (Colom, 2011). She outlines the importance of 
developing a therapeutic relationship between the therapist/group facilitator and the 
patient ‘founded on trust rather than authority’ and which empowers patients to feel 
able to make necessary changes. She acknowledges that this therapeutic trust is 
more difficult to achieve in educational programmes given the relative position of 
power of the facilitator and the comparative lack of time resources compared to 
individual therapy approaches. Future interventions should consider these variables 
when designing such interventions, particularly in the climate of limited resources 
within the NHS. 
 
 Relaxation training was part of all effective interventions in the current review but 
was absent from all but one of the non-effective interventions. Relaxation training 
may play an important role in making interventions helpful in alleviating 
psychological distress and as such is potentially a key consideration and useful 
guide to developing future interventions in this patient group. 
 
 Interestingly, while all but one of the direct illness perception interventions were 
ineffective in improving psychological health, they were successful to some extent 
in improving other specific and perhaps more transient mood-related outcomes in 
the short-term such as ‘anxious preoccupation’ and fear of cancer recurrence, 
symptom distress and ‘negative mood from symptoms’. Heidrich et al., suggest that 
for older cancer patients at least, short-term mood difficulties associated with 
physical symptoms may represent a better target for psychosocial intervention in 
this subgroup of patients with multiple comorbid health concerns than global 
quality of life or general psychological health which may be more stable and/or 
resistant to change.  
 
 Donovan, Kwekkeboom, Rosenzweig, and Ward (2009) recommend that 
psychoeducational and cognitive-behavioural interventions such as those developed 
in the studies reviewed should consider and measure ‘non-specific’ factors which 
may play an important mediational role in the effectiveness of such interventions in 
improving psychological outcomes. Factors such as the therapeutic alliance, 
perceived kindness and compassion, patient expectations and beliefs in the 
credibility of the intervention are all thought to play an important collective role in 
determining whether an intervention will be effective. Donovan et al. also note that 
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these non-specific factors are rarely measured within intervention studies, as was 
the case for the studies reviewed here. 
 
 
 
4.5. Strengths and limitations 
In line with the CRD guidelines and using recommendations detailed in the PRISMA 
checklist for reporting systematic reviews (Moher, Liberati, Tetzlaff, & Altman, 2009), 
strengths and limitations will now be considered at the study level (e.g. confounding 
variables and potential risk of bias), at the review level (e.g. incomplete retrieval of 
identified research, reporting bias) and at the reviewer level (e.g. professional 
perspectives).  
 
 
4.5.1. Study level 
Attrition bias 
Most studies reported data on patients who had completed all measures at all time 
points and provided minimal information on who, how many and why people dropped 
out between baseline and follow up. Although several studies compared completers 
from those who dropped out on demographic variables, very few studies compared the 
groups on psychological health or illness perception variables to determine any 
differences in the ways they think or felt emotionally. It is possible that patients who 
completed the study/intervention were more psychologically or clinically well 
compared to those who dropped out. 
 
Measurement bias 
Another potential source of bias within these reviews could be the use of only self-
report measures of illness perceptions and psychological health and the absence of any 
other objective measure (Robson, 2002). Using only self-report measures relies heavily 
upon patient’s individual interpretation of items. Similarly, most studies did not specify 
exactly where patient’s completed questionnaires which increases the risk that items 
may have been misinterpreted.  However, the absence of other clinically relevant and 
psychometrically valid and reliable ways to measure illness perceptions means this risk 
of bias would always have been present. The fact that most studies used illness 
perception measures as recommended by developers is likely to have increased the 
internal validity of the dataset overall.   
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Sample bias 
Regarding sample bias, several studies in both reviews recruited participants who were 
not necessarily experiencing psychological difficulties at baseline. Study 7 excluded 
patients who were experiencing high levels of anxiety. This finding could mean a lack 
of sensitivity in the ability to detect changes or improvements in psychological health or 
illness perceptions over time (since these perceptions may be relatively stable if 
participants are psychologically ‘well’). Several studies found differences between 
participants who completed all measures at all time points and those who dropped out, 
in terms of both physical or psychological health or levels of social and emotional 
support (Studies 2, 3, 5 & 7). Patients who dropped out of Study 5 for example were not 
only those with worse tumour stages but were also more likely to have had combined 
therapy.  Conversely, patients who remained in the study had been diagnosed earlier in 
their disease progression in line with previous evidence showing a link between high 
patient attrition and the wellbeing of ‘completers’ (Miller et al., 2005).  
 
Only eight studies in both reviews (40%) reported the ethnicity of their sample. Of 
these, seven studies reported more than 90% of patients in the study were Caucasian 
white ethnicity. Given minority groups are equally likely to receive a cancer diagnosis, 
this significant underrepresentation of minority groups depreciates the generalizability 
and validity of findings and may also highlight potential issues surrounding access to 
interventions (Giuliano, et al., 2000). Speaking a primary language other than English 
was an exclusion factor for more than one of the studies in the current review and has 
been cited as a significant barrier to both the participation and recruitment of minority 
groups in cancer studies (Giuliano, et al., 2000). Illness perception studies might benefit 
from knowing the IPQ-R has been translated and is freely available in 16 languages and 
the B-IPQ in 24 languages (http://www.uib.no/ipq/ - accessed on 01/09/2016). 
 
Recruitment point 
There were two main issues surrounding the recruitment of participants for both 
reviews. First, reporting when patients entered the studies or when they received 
intervention was particularly poor. Of the studies that did report the exact time at which 
patients were recruited, there was a great degree of variability in terms of time since 
diagnosis and/or treatment. Some studies reported patients were ‘pre-treatment’, some 
were ‘newly diagnosed’, some were immediately ‘post curative treatment’ and others 
had had a diagnosis for up to 4 years. To draw conclusions about the links between 
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illness representations and psychological health and the efficacy of interventions, this 
information is vital. The Institute for Health Research (2001) suggests that to explore or 
indeed effect psychosocial changes for cancer patients, it is first essential to appreciate 
the differential needs at different points in the cancer trajectory. They hypothesise four 
‘critical moments’ in cancer trajectories distinct from more clinical definitions of cancer 
in ‘stages’. These critical moments are defined as being within one month of: diagnosis, 
the end of the first treatment, the first recurrence and the move from active treatment to 
palliative care only. During these critical moments, patients are significantly more likely 
to suffer psychological distress. Interestingly, Study 14 noted that patients in their 
intervention suggested in qualitative feedback to their facilitators that they would have 
preferred the intervention earlier in their recovery (within 3 months of medical/surgical 
treatment) which lends some support to the idea of critical moments and is worthy of 
consideration when designing studies for cancer patients.   
 
 
Statistical suppression effects 
While illness representations were predictive of future psychological health in 6/7 
studies in Review 1, the strength of this association varied and diminished considerably 
in several studies once the variance explained by other baseline sociodemographic (e.g. 
age, gender, SES) and disease related (cancer type, tumour stage) variables had been 
considered during statistical analysis. Baseline psychological health was the most 
significant predictor of future psychological health in most studies that accounted for 
this variable within regression analyses. The strongest predictive relationship between 
illness representations and future psychological health was reported by Study 4. This 
study did not measure baseline psychological health because it was not appropriate to 
do so at that point in time with this sample of patients and therefore could not be 
controlled for within regression analyses. This may to some extent explain the 
significantly stronger relationship between baseline illness perceptions and follow up 
psychological health observed in this study compared to others which did control for 
this variable. Study 2 for example, found no significant relationship between baseline 
illness perceptions and future psychological health once baseline psychological health 
had been accounted for in regression analyses.  
 
Cook et al., (2015: Study 3) suggested that the true relationship between illness 
perceptions and psychological health may be underestimated in their study, even though 
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it was still statistically significant. They argue that relationship sizes may be artificially 
‘suppressed’ by hierarchical regression analysis due to the strong cross-sectional 
association between Time 1 and Time 2 symptoms of distress. Artificial suppression in 
regression analysis is a distinct possibility for several of the studies reviewed and 
discussed within social science research as introducing potentially confounding effects 
(Ludlow & Klein, 2014). 
 
 
4.5.2. Review level 
There were several strengths of the two reviews. Current guidelines on best practice in 
systematic reviews were followed to ensure a rigorous approach to searching the 
literature base to improve the chances that key studies were not missed. Reporting the 
search process using these and other national review guidelines (Moher, Liberati, 
Tetzlaff, & Altman, 2009) improved the transparency of the review, increasing its 
replicability and likelihood of publication. The study selection criteria were deliberately 
over-inclusive to ensure all relevant studies were retrieved. Several checks to ensure all 
relevant papers had been retrieved such as contacting relevant authors and hand 
searching key journals is also likely to have reduced the likelihood of publication bias. 
Studies were also subjected to rigorous evidence based methodological and reporting 
quality assessment to attenuating the risk of bias (EPPI-Centre; Katrak et al., 2004; 
Harden et al., 2001).  
 
In terms of the potential limitations, only peer reviewed papers published in the English 
language were included which may have led to publication bias. Had it been feasible in 
terms of time and resources, this could have been minimised by including non-English 
papers and making use of translation services. It may also have been possible to include 
non-peer reviewed ‘grey-literature’ in the inclusion criteria, which may have reduced 
the possibility of including only significant findings (Garg, Hackam, & Tonelli, 2008).  
 
 
4.5.3. Reviewer level 
CRD guidelines recommend reviews are conducted by a ‘review team – a minimum of 
two reviewers, who can minimize bias and error throughout all stages of the review’. 
The guidelines also recommend the review team consults with an ‘advisory group’ 
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which might consist of both clinical and research professionals to provide a range of 
clinical expert skills in the review process. As the candidate for this thesis, I was the 
primary and only reviewer. It was neither possible due to time and resource constraints 
to have a team of reviewers nor an advisory group. Nevertheless, I have received 
training in conducting systematic reviews using recommended guidelines and I was able 
to make use of both a field supervisor with expertise in using the CSM model and 
working in cancer research and an academic supervisor with significant expertise in 
research methods and systematic reviews. Substantial attempts were made to make use 
of supervisor’s expertise at various points (already outlined) in the literature search and 
data extraction to minimise bias.  However, as noted within the CRD guidelines, 
sometimes data extraction can be prone to human error and often subjective decisions 
are required. As with any systematic review, my occupation as a Clinical Psychologist 
may have introduced a level of subjective bias to the review process since I have my 
own ideas about what might be useful for clinicians to know about the studies reviewed 
and have used these opinions to develop the parameters of the search strategy (e.g. 
evaluating only psychological health outcomes and excluding other outcomes which 
could have potentially been useful for interpreting the data). While the use of 
standardised guidelines for limiting the potential for bias in several ways has been 
helpful to attenuate this subjectivity, undoubtedly bias could have been further reduced 
by having one or more additional reviewers.  
 
 
 
4.6. Conclusions 
The common-sense model of illness representations is a widely cited theoretical 
framework within health literature to explain the ways in which individuals with 
chronic illness think about and respond to their condition (Leventhal & Diefenbach, 
1992; Leventhal & Nerenz, 1985). Since the development of quantitiative measures of 
illness representations over the last 20 years, studies exploring the relationship between 
illness perceptions and psychological health have grown exponentially, particularly and 
more recently in the field of cancer research.  Review 1 aimed to identify studies which 
had measured the prospective relationship between illness representations and 
psychological health in order to investigate the potential of illness representations as a 
modifiable target to guide interventions for adults struggling to cope with having 
cancer.  
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In total, seven studies were identified which had measured this relationship. An inverse 
relationship was found for six of these studies indicating that the more negative illness 
perceptions patients have about their cancer, the worst their overall psychological health 
was likely to be in the future. Review 2 aimed to identify interventions which had 
attempted to improve the psychological health of cancer patients by modifying illness 
perceptions. Thirteen intervention studies were identified and revealed that seven 
studies reported interventions that had attempted to improve psychological health by 
indirectly affecting change in illness perceptions (not targetting illness beliefs 
specifically) and a further six studies had attempted to directly manipulate patient’s 
illness perceptions. Findings revealed that on the whole, indirect interventions were the 
most effective in improving psychological health. Most direct illness perception 
interventions were not effective in improving psychological health. Indirect 
interventions were more likely to be complex, comprising multiple facets which may 
have facilitated their efficacy. Interventions were more likely to be effective in 
improving psychological health if they were run as a group programme, did not attempt 
to directly modify illness perceptions, were delivered weekly over several weeks and 
included relaxation training. These findings are likely to be particularly useful in 
planning future research studies and guiding psychosocial interventions for this 
particularly vulnerable patient group. 
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APPENDICES 
Appendix I – Illness Perception Questionnaire – Revised (Moss-Morris et al., 
2002) 
 
 
ILLNESS PERCEPTION QUESTIONNAIRE 
(IPQ-R) 
 
  
Name………………………………       Date…………………………………  
  
YOUR VIEWS ABOUT YOUR ILLNESS  
Listed below are a number of symptoms that you may or may not have experienced 
since your illness.  Please indicate by circling Yes or No, whether you have 
experienced any of these symptoms since your illness, and whether you believe that 
these symptoms are related to your illness.  
 
  
      
 I have experienced this   This symptom is related to  
symptom since my illness  my illness   
Pain        Yes    No  ________________  Yes    No  
Sore Throat      Yes    No  ________________  Yes    No  
Nausea       Yes    No  ________________  Yes    No  
Breathlessness     Yes    No  ________________  Yes    No  
Weight Loss      Yes    No  ________________  Yes    No  
Fatigue     Yes    No  ________________  Yes    No  
Stiff Joints      Yes    No  ________________  Yes    No  
Sore Eyes      Yes    No  ________________  Yes    No  
Wheeziness      Yes    No  ________________  Yes    No  
Headaches      Yes    No  ________________  Yes    No  
Upset Stomach     Yes    No  ________________   Yes    No  
Sleep 
Difficulties  
  Yes    No  ________________  Yes    No  
Dizziness      Yes    No  ________________  Yes    No  
Loss of 
Strength  
  Yes    No  ________________  Yes    No  
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We are interested in your own personal views of how you now see your current illness.  
  
Please indicate how much you agree or disagree with the following statements about 
your illness by ticking the appropriate box.  
 
  
  
VIEWS ABOUT YOUR 
ILLNESS 
STRONGLY 
DISAGREE DISAGREE 
NEITHER 
AGREE NOR 
DISAGREE 
AGREE STRONGLY 
AGREE 
IP1  My illness will last a short time  
          
IP2  
My illness is likely to be permanent rather 
than temporary  
          
IP3  My illness will last for a long time  
          
IP4  This illness will pass quickly  
          
IP5  
I expect to have this illness for the rest of my 
life  
          
IP6  My illness is a serious condition  
          
IP7  
My illness has major consequences on my 
life  
          
IP8  
My illness does not have much effect on my 
life  
          
IP9  
My illness strongly affects the way others 
see me  
          
IP10  
My illness has serious financial 
consequences  
          
IP11  
My illness causes difficulties for those who 
are close to me  
          
IP12  
There is a lot which I can do to control my 
symptoms  
          
IP13  
What I do can determine whether my illness 
gets better or worse  
          
IP14  The course of my illness depends on me  
          
IP15  Nothing I do will affect my illness  
          
IP16  I have the power to influence my illness  
          
IP17  
My actions will have no effect on the 
outcome of my illness  
          
IP18  My illness will improve in time  
          
134 
 
 
VIEWS ABOUT YOUR 
ILLNESS 
STRONGLY 
DISAGREE 
DISAGREE 
NEITHER 
AGREE NOR 
DISAGREE 
AGREE 
STRONGLY 
AGREE 
IP19  
There is very little that can be done to 
improve my illness  
          
IP20  
My treatment will be effective in curing my 
illness  
          
IP21  
The negative effects of my illness can be 
prevented (avoided) by my treatment  
          
IP22  My treatment can control my illness  
          
IP23  
There is nothing which can help my 
condition  
          
IP24  
The symptoms of my condition are puzzling 
to me  
          
IP25  My illness is a mystery to me  
          
IP26  I don’t understand my illness  
          
IP27  My illness doesn’t make any sense to me  
          
IP28  
I have a clear picture or understanding of my 
condition  
          
IP29  
The symptoms of my illness change a great 
deal from day to day  
          
IP30  My symptoms come and go in cycles  
          
IP31  My illness is very unpredictable  
          
IP32  
I go through cycles in which my illness gets 
better and worse.  
          
IP33  I get depressed when I think about my illness  
          
IP34  When I think about my illness I get upset  
          
IP35  My illness makes me feel angry  
          
IP36  My illness does not worry me  
          
IP37  Having this illness makes me feel anxious  
          
IP38  My illness makes me feel afraid  
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CAUSES OF MY ILLNESS   
  
We are interested in what you consider may have been the cause of your illness.  As people 
are very different, there is no correct answer for this question.  We are most interested in 
your own views about the factors that caused your illness rather than what others including 
doctors or family may have suggested to you.  Below is a list of possible causes for your 
illness.  Please indicate how much you agree or disagree that they were causes for you by 
ticking the appropriate box.  
 
  
  
POSSIBLE CAUSES 
STRONGLY 
DISAGREE DISAGREE 
NEITHER 
AGREE 
NOR 
DISAGREE 
AGREE STRONGLY 
AGREE 
C1  Stress or worry            
C2  Hereditary - it runs in my family            
C3  A Germ or virus            
C4  Diet or eating habits            
C5  Chance or bad luck            
C6  Poor medical care in my past            
C7  Pollution in the environment            
C8  My own behaviour            
C9  
My mental attitude e.g. thinking about life 
negatively  
          
C10  
Family problems or worries caused my 
illness  
          
C11  Overwork            
C12  
My emotional state e.g. feeling down, 
lonely, anxious, empty  
          
C13  Ageing            
C14  Alcohol            
C15  Smoking            
C16  Accident or injury            
C17  My personality            
C18  Altered immunity            
  
 
In the table below, please list in rank-order the three most important factors that you now believe caused 
YOUR illness.   You may use any of the items from the box above, or you may have additional ideas of 
your own.  
 
The most important causes for me:-  
1. _______________________________________   
2. _______________________________________  
3. _______________________________________   
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Appendix II – Example search strategy for MEDLINE 
 
MEDLINE was searched using the Ovid interface on 02/05/13 for the period 1996 to 
2013 using the following search strategy; 
 
1. Exp Cancer/ 
2. Exp Neoplasm$/ 
3. Cancer adj (skin or liver or breast or testicular or bowel or lung or anal or 
bile?duct or bladder or bone or brain or colon or rectal or eye or fallopian$ or 
gall?bladder or head or neck or kidney or larynx or lymph?node or ovarian or 
oesophag$ or pancrea$ or penis or prostate or small?bowel or stomach or 
thymus or thyroid or trachea or primary or vagina or secondary or vulva or 
womb or endometri$). ti,ab. 
4. Malignan$. ti,ab. 
5. Exp oncolog$/ 
6. Tumo?r. ti,ab. 
7. Tumo?r adj (brain, endocrine, neuro?endocrine, spinal cord, secondary). ti,ab. 
8. Exp sarcoma/ 
9. Exp carcinoma/ 
10. Leuk?emia. ti,ab. 
11. Leukaemia adj (acute, chronic, lymphoblast$, myeloid). ti,ab. 
12. Lymphoblast$. ti,ab. 
13. Lymphoma. ti,ab. 
14. Lymphoma adj (Hodgkin$, non?hodgkin). ti,ab. 
15. Mesothelioma.ti,ab. 
16. Myeloma. ti,ab. 
17. Pseudomyxoma. ti,ab. 
18. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17 
19. Illness adj (perception$ or represent$ or cognition$) 
20. “Illness Perception Questionnaire” 
21. IPQ$ 
22. Self adj regulat$ adj (model or theory) 
23. Exp attribution$/ 
24. Common adj sense adj (model or theory) 
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25. Causal adj attribution$ 
26. Illness adj coherence 
27. Illness adj identity 
28. Emotion$ adj represent$ 
29. Cognitive adj represent$ 
30. 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 
31. Exp distress/ 
32. Exp stress/ 
33. Exp well?being/ 
34. Exp adjust$/ 
35. Exp adaptation/ 
36. Exp recover$/  
37. Exp emotion$/ 
38. Exp anxiety/ 
39. Exp depression 
40. Exp mood/ 
41. Exp coping/ 
42. Exp worry/ 
43. Exp happiness/ 
44. Life adj satisfaction/ 
45. Exp “quality of life”/ 
46. Psycholog$ adj (distress or health or stress or well?being or function$ or adapt$ 
or adjust$ or recover$ or quality of life). ti,ab. 
47. Emotion$ adj (distress or health or stress or well?being or function$ or adapt$ or 
adjust$ or recover$ or quality of life). ti,ab. 
48. Mental adj (distress or health or stress or well?being or function$ or adapt$ or 
adjust$ or recover$ or quality of life). ti,ab. 
49. (positive or negative) adj (mood or mental adj health or cognition$ or affect$) 
50. (eudemonic or affective or evaluative) adj (wellbeing or well?being) 
51. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 
45 or 46 or 47 or 48 or 49 or 50 
52. 18 and 30 and 51 
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Appendix III: Data extraction form for Review 1 
 
General information 
Date of data extraction:…………..….......... 
Author(s) & citation:………………………………………………………………........ 
Title:………………..………………………………………………………………….…
……………………………………………………………………………………………. 
 
 
Study characteristics 
Aim/objectives of the study:……..……………………………..…………………....…... 
.............................................................................................................................................
............................................................................................................................................. 
 
Study design: 
 RCT        Non-randomised controlled trial       Cohort study      Observation study 
 Case-control study         Time-series            Cross-sectional study        Case series 
 Post-test case series     Before/after study 
  
Number of times of follow-up: .......................................................................................... 
Length of follow-up: ........................................................................................................... 
Recruitment procedures used (e.g. details of randomization, blinding): 
…………..……………..…………………………………………………………………
……………………………………………………………………………………………. 
Consent rate:…………………………………………………………………………….... 
 
 
Participant characteristics 
Age (mean):………………….      Gender ratio:……...…………..…………………….. 
Ethnicity:............................................................................................................................ 
Socioeconomic status:……..………………….…………………………………………. 
Cancer type:….................…..............………….………………………………………… 
Co-morbidities:………...……………………………………………………………….. 
Time post diagnosis (mean & range):……………...........…………………...………… 
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Setting 
Setting description(s):……………………..……………………….…………………….. 
……………………………………………………………………………………………
……………………………………………………………………………………………. 
Description of the control (if applicable): 
...........................................................……..........................…………………………….. 
…………………………………………………………………………………………… 
Number of participants enrolled: 
Total:.....................     Experimental group:.............................  Control: ........................... 
Number of participants lost to attrition, exclusion & follow-up: 
Total: ......................   Experimental group: ............................  Control: ...........................  
 
 
Measures used 
Psychological health measures used: 
.............................................................................................................................................
............................................................................................................................................. 
Total number of psychological measures used: ................................................................. 
 
Definition provided for: 
 All illness peerceptions measured     Outcome measure 1      Outcome measure 2 
 Outcome measure 3            Outcome measure 4            Outcome measure 5 
 
Illness perception measure used:  
 IPQ       IPQ-R        IPQ-B       
Illness perception constructs measured: 
 Cause 
 Consequence 
 Illness Coherence 
 Identity 
 Timeline     acute-chronic    cyclical 
 Emotional representations 
 Cure/controllability    Personal     Treatment  
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Modifications to IPQ/IPQR:............................................................................................... 
.............................................................................................................................................
.............................................................................................................................................
............................................................................................................................................. 
 
 
Results/analysis 
Results reported for: 
 All illness perceptions measured 
 Outcome measure 1    Outcome measure 2     Outcome measure 3         
 Outcome measure 4            Outcome measure 5 
 
Summary outcome data: 
........…………….……………………………………………………………………….. 
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………. 
……………………………………………………………………………………………. 
Type of analysis used in study: 
……………………………………..................………………….………..……………… 
……………….……………………………………………………………………………
……..................................................................................................................................... 
 
 
Authors conclusions: 
 
 
 
Reviewers comments: 
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Appendix IV: Data extraction form for Review 2 
 
General information 
Date of data extraction:…………..….......... 
Author(s) & citation:………………………………………………………………........ 
Title:………………..………………………………………………………………….…
……………………………………………………………………………………………. 
 
 
Study characteristics 
Aim/objectives of the study:……..……………………………..…………………....…... 
.............................................................................................................................................
............................................................................................................................................. 
 
Study design: 
 RCT        Non-randomised controlled trial       Cohort study      Observation study 
 Case-control study         Time-series            Cross-sectional study        Case series 
 Post-test case series     Before/after study 
  
Number of times of follow-up: .......................................................................................... 
Length of follow-up: ........................................................................................................... 
Recruitment procedures used (e.g. details of randomization, blinding): 
…………..……………..…………………………………………………………………
……………………………………………………………………………………………. 
Consent rate:…………………………………………………………………………….... 
 
 
Participant characteristics 
Age (mean):………………….      Gender ratio:……...…………..…………………….. 
Ethnicity:............................................................................................................................ 
Socioeconomic status:……..………………….…………………………………………. 
Cancer type:….................…..............………….………………………………………… 
Co-morbidities:………...……………………………………………………………….. 
Time post diagnosis (mean & range):……………...........…………………...………… 
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Intervention & setting 
Setting(s):……………………………………..……………………….………………….. 
Description of the intervention & control (if applicable): 
...........................................................……..........................…………………………….. 
……………………………………………………………………………………………
…………………………………………………………………………………………… 
Description of co-interventions (if applicable): 
...........................................…………….………………………………………………… 
……………………………………………………………………………………………
……………………………………………………………………………………………. 
Number of participants enrolled: 
Total:.........................     Intervention:......................................  Control: ........................... 
Number of participants lost to attrition, exclusion & follow-up: 
Total: ............................ Intervention: ...................................    Control: ...........................  
 
 
Measures used 
Psychological health measures used: …………………………………............................ 
……………………………………………………………………………………………. 
Total number of psychological measures used: ................................................................. 
 
Definition provided for: 
 All illness perceptions measured     Outcome measure 1      Outcome measure 2 
 Outcome measure 3            Outcome measure 4            Outcome measure 5 
 
Illness perception measure used:  
 IPQ       IPQ-R        IPQ-B       Other: ...................................................................... 
 
Illness perception constructs measured: 
 Cause      Consequence         Illness Coherence         Identity        
 Timeline     acute-chronic    cyclical 
 Emotional representations 
 Cure/controllability    Personal     Treatment  
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Modifications to IPQ/IPQR:............................................................................................... 
.............................................................................................................................................
.............................................................................................................................................
............................................................................................................................................. 
 
 
Results/analysis 
Results reported for: 
 All illness perceptions measured       Outcome measure 1    Outcome measure 2 
 Outcome measure 3            Outcome measure 4            Outcome measure 5 
 
Summary outcome data: 
........…………….……………………………………………………………………….. 
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………. 
…………………………………………………………………………………………… 
Type of analysis used in study: 
…………………………………..................………………….………..……………… 
……………….……………………………………………………………………………
……..................................................................................................................................... 
 
 
Authors conclusions: 
 
 
 
 
Reviewers comments: 
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Appendix V – Study quality appraisal tool 
 
 Criteria Yes No Partly NA 
O
v
er
a
ll
 
1.Based on theoretical framework 
    
2.Well defined research 
question/hypotheses 
    
M
et
h
o
d
o
lo
g
ic
a
l 
d
es
ig
n
 
3.Appropriate methods used to answer 
research question 
    
4.Appropriate recruitment procedure 
    
5.Adequate sample size for statistical 
analysis 
    
6.Measures taken to reduce bias (e.g. 
sampling methods, randomisation, 
blinding) 
    
7.Equal group numbers 
    
8.Groups well matched at baseline 
    
9.Use of valid and reliable psychological 
health measures 
    
10.Recommended use of psychological 
health measure(s) 
    
11.Recommended use of illness 
perception measure 
    
12.Acceptable internal consistency of 
measures 
    
13.Adequate length of follow-up 
    
R
es
u
lt
s 
14.Appropriate quantitative analysis to 
test hypothesis 
    
15.Accurate interpretation of findings 
    
16.Conclusions consistent with results 
    
17.Findings generalizable 
    
Total 
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Appendix VI – Reporting quality appraisal tool 
 
 Criteria Yes No Partly NA 
Q
u
a
li
ty
 o
f 
re
p
o
rt
in
g
 
1.Clearly reported aims & objectives 
    
2.Clear description of sample 
    
3.Clear description of setting 
    
4.Clear description of recruitment 
procedures 
    
5.Clear description of intervention 
    
6.Clear description of control group(s) 
    
7.Clear definition of psychological health 
measure 
    
8.Clear description of data collection 
    
9.Reliability of administered measures 
reported 
    
10.Clear description of data analysis 
conducted 
    
11.Provision of attrition data 
    
12.Strengths and limitations stated 
    
13.Problems with study design reported 
    
14.Confounding factors reported 
    
15.Discussion of clinical relevance of 
findings 
    
16.Recommendations for clinical practice 
discussed 
    
Total 
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